Cosmetic compositions comprising water-in-oil emulsions

A crosslinked polyester elastomer and Polyglyceryl-6 Polyricinoleate emulsifiers in cosmetic compositions achieve stable water-in-oil emulsions with high water content, addressing environmental concerns and enhancing user experience without silicones.

WO2026234622A1PCT designated stage Publication Date: 2026-11-12LOREAL SA +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/IB2026/054547
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-09-25
Filing Date
2026-05-07
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Cosmetic compositions relying on silicone-based emulsifiers face environmental concerns and stability issues with high internal water phase concentrations, limiting their appeal to environmentally conscious consumers and those with sensitive skin.

Method used

A cosmetic composition using a crosslinked polyester elastomer and Polyglyceryl-6 Polyricinoleate as emulsifiers, combined with ascorbic acid, creates a stable water-in-oil emulsion with a high internal water phase concentration, achieving stability and desirable texture without silicones.

Benefits of technology

The composition maintains emulsion stability, enhances user experience with a transformative texture, and provides effective antioxidant benefits, while reducing reliance on petrochemical compounds and silicones.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure IMGF000003_0001
    Figure IMGF000003_0001
  • Figure IMGF000003_0002
    Figure IMGF000003_0002
  • Figure IMGF000009_0001
    Figure IMGF000009_0001
Patent Text Reader

Abstract

A cosmetic composition comprising an emulsion system comprising at least two emulsifiers including from 1% to about 10% of an elastomer gel that comprises a crosslinked polyester elastomer and a solvent, from about 0.2% to about 1% of Polyglyceryl-6 Polyricinoleate; and ascorbic acid or a derivative thereof; wherein the composition is a water-in-oil emulsion comprising an oil phase and an internal water phase. When subjected to shear, the composition releases the water phase from the oil phase and melts from a thick cream to a watery liquid. The cosmetic composition may be free of silicone.
Need to check novelty before this filing date? Find Prior Art

Description

Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCTCOSMETIC COMPOSITIONS COMPRISING WATER-IN-OIL EMULSIONS RELATED APPLICATIONS

[0001] This application claims the benefit of U.S. App. No. 19 / 203,603 filed May 9, 2025 (DAS 2641), and FR App. No. 2510970 filed September 25, 2025 (DAS 1A9D), the contents of which are incorporated herein by reference in their entireties.FIELD

[0002] The present invention relates to a cosmetic composition comprising an emulsion system of at least two emulsifiers, specifically a crosslinked polyester elastomer emulsifier, and ascorbic acid or one of its derivatives, formulated as a water-in-oil emulsion.BACKGROUND

[0003] Cosmetic compositions such as creams and lotions often employ emulsifiers to achieve stable water-in-oil emulsions. Traditional emulsions utilize various silicone-based emulsifiers and other silicone ingredients to maintain stability and enhance product feel. However, silicones can cause environmental concerns due to their non-biodegradable nature. Additionally, achieving a stable water-in-oil emulsion with a high internal water phase concentration often requires complex formulations to prevent phase separation and maintain product texture and sensory properties, and is difficult to achieve without silicones. Thus, while these compositions can effectively encapsulate active ingredients like ascorbic acid, their reliance on silicones limits their appeal to environmentally conscious consumers and those with sensitive skin.

[0004] However, the formulation of cosmetic products, whose design and development take into account environmental issues, is becoming a major concern to help meet global challenges. It is therefore essential to offer more sustainable compositions that make it possible to meet these environmental challenges by reducing the use of compounds of petrochemical origin. To address this need, Momentive offers polyester elastomers obtained by the reaction of an activated polycarboxylic acid and a polyol in its patent application WO 2024 / 206504. These polymers have good rheological properties and improve the sensory performance of cosmetic or dermatological compositions. However, the introduction of this type of polymer into cosmetic or dermatologicalAttorney Docket No. OA25160-WO-PCT / 31710-7189-PCTcompositions in order to obtain a stable and homogeneous composition is not always easy, especially in the presence of volatile solvents such as volatile hydrocarbons or ethanol, which can be used to bring lightness to products.

[0005] The problems addressed by the present invention include the need for a cosmetic composition that provides a stable water-in-oil emulsion with a high internal water phase concentration that preserves the stability of ascorbic acid in the water phase even in the absence of silicones and without compromising on texture or stability, and providing a composition with good cosmetic properties and a better carbon footprint, in particular by promoting the use of renewable raw materials and / or with a good index of naturalness and / or natural origin while reducing the use of compounds of petrochemical origin.

[0006] SUMMARY

[0007] This disclosure describes exemplary embodiments in accordance with the general inventive concepts and is not intended to limit the scope of the invention in any way. Indeed, the invention as described in the specification is broader than and unlimited by the exemplary embodiments set forth herein, and the terms used herein have their full ordinary meaning.

[0008] According to an embodiment of the invention, a cosmetic composition comprising a emulsion system comprising at least two emulsifiers, wherein the emulsifiers comprise from about 1% to about 10% of an elastomer gel that comprises a crosslinked polyester elastomer and a solvent, by weight, based on the weight of the composition; and from about 0.2% to about 1% of Polyglyceryl-6 Polyricinoleate, by weight, based on the weight of the composition; and ascorbic acid or a derivative thereof; wherein the crosslinked polyester elastomer is selected from elastomers included in the disclosure in W02024206504A1, which is incorporated herein by reference, and in some embodiments, the elastomer comprises a reaction product of:

[0009] (i) at least one di-carboxylic acid or tri-carboxylic acid; (ii) at least one monocarboxylic acid; and (iii) at least one polyol, wherein the at least one di-carboxylic acid is a compound of formula (IA)o oL JL(,A)Her R1AOHAttorney Docket No. OA25160-WO-PCT / 31710-7189-PCT

[0010] wherein R1Ais C2-C52 alkyl group, C2-C52 heteroalkyl group, C2-C52 alkene group, C2-C52 heteroalkene group, C3-C52 cyclic group, or C2-C52 heterocyclic group,

[0011] and wherein the at least one tri-carboxylic acid is a compound of formula (IB)

[0012] wherein R1Bis C2-C52 alkyl group, C2-C52 heteroalkyl group, C2-C52 alkene group, C2-C52 heteroalkene group, C3-C52 cyclic group, or C2-C52 heterocyclic group,

[0013] and wherein the at least one mono- carboxylic acid is a compound of formula (II) oII (II)R2OH

[0014] wherein R2is C2-C52 alkyl group, C2-C52 heteroalkyl group, C2-C52 alkene group, C2-C52 heteroalkene group, C3-C52 cyclic group, or C2-C52 heterocyclic group,

[0015] and wherein the at least one polyol is a compound of formula (III)R3— OH n <r,I>

[0016] wherein R3is C3-C50 alkyl group, C3-C50 heteroalkyl group, C3-C50 alkene group, C3-C50 heteroalkene group, C3-C50 cyclic group, or C3-C50 heterocyclic group; and n is an integer from 2 to 10, and in some particular embodiments, the elastomer comprises Polyglyceryl-2 Isostearate / Dimer Dilinoleate Copolymer. In some embodiments, the composition is a water-in-oil emulsion comprising an oil phase and an internal water phase with a concentration of the internal water phase that is at least about 74%, by weight, based on the weight of the composition. In some embodiments, the elastomer gel and Polyglyceryl-6 Polyricinoleate are present in a ratio of elastomer gel to Polyglyceryl-6 Polyricinoleate that is at least 1 : 1 by weight, based on the weight of each ingredient, and wherein the combination of elastomer gel and Polyglyceryl-6 Polyricinoleate is at least 2%, by weight, based on the weight of the composition. In some embodiments the elastomer gel and Polyglyceryl-6 Polyricinoleate are present in a ratio ofAttorney Docket No. OA25160-WO-PCT / 31710-7189-PCTelastomer gel to Polygly eery 1-6 Polyricinoleate that is in a range from about 1 : 1 to about 20: 1 by weight, based on the weight of each ingredient. In some embodiments, the composition demonstrates one or more of the following: (i) a viscosity in a range from about 30,000 cP to about 300,000 cP; (ii) emulsion and viscosity stability when exposed to at least ten 24-hour freeze / thaw cycles at freezing temperatures of about -20 °C and thaw temperatures of about 25 °C; (iii) stability of the ascorbic acid or derivative thereof as demonstrated by lack of precipitation and crystallization, and lack of visibly detectable color change after at least two months at ambient and elevated temperatures of about 25 °C and 45 °C, respectively; (iv) resistance to pilling or noodling on application of shear when applied to a keratinous substate at a temperature of about 25 °C; (v) when subjected to shear, the composition releases the water phase from the oil phase and melts from a thick cream to a watery liquid; and (vi) combinations thereof.

[0017] In some embodiments, the disclosure provides a cosmetic composition comprises a emulsion system comprising at least two emulsifiers, wherein the emulsifiers comprise from about 1% to about 10% of elastomer gel, by weight, based on the weight of the composition, the elastomer gel comprising Polyglyceryl-2 Isostearate / Dimer Dilinoleate Copolymer; and from about 0.2% to about 1% of Polygly ceryl-6 Polyricinoleate, by weight, based on the weight of the composition; and ascorbic acid or a derivative thereof. In some embodiments, the composition is a water-in-oil emulsion comprising an oil phase and an internal water phase with a concentration of the internal water phase that is at least about 74%, by weight, based on the weight of the composition, and wherein the Polyglyceryl-2 Isostearate / Dimer Dilinoleate Copolymer elastomer gel and Polyglyceryl-6 Polyricinoleate are present in a ratio of Polyglyceryl-2 Isostearate / Dimer Dilinoleate Copolymer elastomer gel to Polyglyceryl-6 Polyricinoleate that is at least 1 : 1 by weight, based on the weight of each ingredient, and wherein the combination of the Polyglyceryl-2 Isostearate / Dimer Dilinoleate Copolymer elastomer gel and Polyglyceryl-6 Polyricinoleate is at least 2%, by weight, based on the weight of the composition In some embodiments, the composition demonstrates one or more of the following: (i) a viscosity in a range from about 30,000 cP to about 300,000 cP; (ii) emulsion and viscosity stability when exposed to at least ten 24-hour freeze / thaw cycles at freezing temperatures of about -20 °C and thaw temperatures of about 25 °C; (iii) stability of the ascorbic acid or derivative thereof as demonstrated by lack of precipitation and crystallization, and lack of visibly detectable color change after at least two months at ambient and elevated temperatures of about 25 °C and 45 °C,Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCTrespectively; (iv) resistance to pilling or noodling on application of shear when applied to a keratinous substate at a temperature of about 25 °C; (v) when subjected to shear, the composition releases the water phase from the oil phase and melts from a thick cream to a watery liquid; and (vi) combinations thereof.

[0018] In some embodiments, the elastomer gel comprising Polyglyceryl-2 Isostearate / Dimer Dilinoleate Copolymer is present in a range from about 5% to about 10%, by weight, based on the weight of the composition.

[0019] In some embodiments, Polyglyceryl-6 Polyricinoleate is present in a range from about 0.5% to about 1%, by weight, based on the weight of the composition.

[0020] In some embodiments, the composition includes at least one additional emulsifier that is different from Polyglyceryl-2 Isostearate / Dimer Dilinoleate Copolymer and Polyglyceryl-6 Polyricinoleate. In some embodiments, the composition excludes an emulsifier selected from the group consisting of Polyglyceryl-4 Isostearate, Polyglyceryl-3 Diisostearate, Polyglyceryl-3 Polyricinoleate, Polyglyceryl-4 Diisostearate / Polyhydroxystearate / Sebacate (And) Caprylic / Capric Triglyceride (And) Polyglyceryl-3 Oleate (And) Diisostearoyl Polyglyceryl-3 Dimer Dilinoleate, Polyglyceryl-3 Diisostearate, Polyglyceryl-3 Polyricinoleate, Polyglyceryl-4 Diisostearate / Polyhydroxystearate / Sebacate, and combinations thereof.

[0021] In some embodiments, ascorbic acid is present in the composition in a range from about 5% to about 20%, by weight, based on the weight of the composition.

[0022] In some embodiments, the internal water phase is present in a range from about 74% to about 90%, by weight, based on the weight of the composition.

[0023] In some embodiments, the oil phase does not exceed 20%, by weight, based on the weight of the composition.

[0024] In some embodiments, water is present in a range from about 40% to about 70%, by weight, based on the weight of the composition.

[0025] In some embodiments, the composition includes at least one additional ingredient selected from the group consisting of Cl 5-19 Alkane, Isoamyl Laurate, Tocopherol, Glycerin,Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCTMagnesium Sulfate, Tetrasodium Glutamate Diacetate, Pentylene Glycol, Hydroxyacetophenone, Zingiber Officinale (Ginger) Root Extract, Hydroxypropyl Tetrahydropyrantriol, Gentiana Lutea Root Extract, Sodium Hydroxide, Titanium Dioxide (And) Mica, and combinations thereof. In some embodiments, the composition comprises additional ingredients that include C15-19 alkane (-3%), isoamyl laurate (-2%), tocopherol (-0-1%), glycerin (-7%), magnesium sulfate (-2%), tetrasodium glutamate diacetate (-0.3%), pentylene glycol (-3%), hydroxyacetophenone (-0.5%), zingiber officinale (ginger) root extract (-0-0.1%), hydroxypropyl tetrahydropyrantriol (-0-4%), gentiana lutea root extract (-0-0.5%), sodium hydroxide (-1.5-4%), titanium dioxide (and) mica (-0-0.9%), or a combination thereof, all amounts by weight, based on the weight of the composition.

[0026] In some embodiments, the internal water phase is present at about 89%, by weight, based on the weight of the composition.

[0027] In some embodiments, ascorbic acid is present in the composition in a range from about 7% to about 15%, by weight, based on the weight of the composition.

[0028] In some embodiments, the disclosure provides a cosmetic composition that comprises a emulsion system comprising at least two emulsifiers comprising Polyglyceryl-2 Isostearate / Dimer Dilinoleate Copolymer present in an elastomer gel that also comprises solvent; and Polyglyceryl-6 Polyricinoleate; and ascorbic acid or a derivative thereof, wherein the composition is a water-in-oil emulsion comprising an oil phase and an internal water phase with a concentration of the internal water phase that is at least about 74%, by weight, based on the weight of the composition. In some embodiments, the composition is free of silicone elastomers, or other silicones. In some embodiments, the Polyglyceryl-2 Isostearate / Dimer Dilinoleate Copolymer elastomer gel and Polyglyceryl-6 Polyricinoleate are present in a ratio of the Polyglyceryl-2 Isostearate / Dimer Dilinoleate Copolymer elastomer gel to Polyglyceryl-6 Polyricinoleate that is at least 1 : 1 by weight, based on the weight of each ingredient. In some embodiments the Polyglyceryl-2 Isostearate / Dimer Dilinoleate Copolymer elastomer gel and Polyglyceryl-6 Polyricinoleate are present in a ratio of Polyglyceryl-2 Isostearate / Dimer Dilinoleate Copolymer elastomer gel to Polyglyceryl-6 Polyricinoleate that is in a range from about 1 : 1 to about 20: 1 by weight, based on the weight of each ingredient. In some embodiments,Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCTthe composition demonstrates one or more of the following: (i) a viscosity in a range from about 30,000 cP to about 300,000 cP; (ii) emulsion and viscosity stability when exposed to at least ten 24-hour freeze / thaw cycles at freezing temperatures of about -20 °C and thaw temperatures of about 25 °C; (iii) stability of the ascorbic acid or derivative thereof as demonstrated by lack of precipitation and crystallization, and lack of visibly detectable color change after at least two months at ambient and elevated temperatures of about 25 °C and 45 °C, respectively; (iv) resistance to pilling or noodling on application of shear when applied to a keratinous substate at a temperature of about 25 °C; (v) when subjected to shear, the composition releases the water phase from the oil phase and melts from a thick cream to a watery liquid; and (vi) combinations thereof.

[0029] In some embodiments, the combination of the Polyglyceryl-2 Isostearate / Dimer Dilinoleate Copolymer elastomer gel and Polyglyceryl-6 Polyricinoleate is at least 2%, by weight, based on the weight of the composition.

[0030] In some embodiments, the Polyglyceryl-2 Isostearate / Dimer Dilinoleate Copolymer elastomer gel is present from about 1% to about 10%, by weight, based on the weight of the composition.

[0031] In some embodiments, Polyglyceryl-6 Polyricinoleate is present from about 0.2% to about 1%, by weight, based on the weight of the composition.

[0032] In some embodiments, the composition includes at least one additional ingredient selected from the group consisting of Cl 5-19 Alkane, Isoamyl Laurate, Tocopherol, Glycerin, Magnesium Sulfate, Tetrasodium Glutamate Diacetate, Pentylene Glycol, Hydroxyacetophenone, Zingiber Officinale (Ginger) Root Extract, Hydroxypropyl Tetrahydropyrantriol, Gentiana Lutea Root Extract, Sodium Hydroxide, Titanium Dioxide (And) Mica, and combinations thereof, the composition comprises additional ingredients that include Cl 5-19 alkane (-3%), isoamyl laurate (-2%), tocopherol (-0-1%), glycerin (-7%), magnesium sulfate (-2%), tetrasodium glutamate diacetate (-0.3%), pentylene glycol (-3%), hydroxyacetophenone (-0.5%), zingiber officinale (ginger) root extract (-0-0.1%), hydroxypropyl tetrahydropyrantriol (-0-4%), gentiana lutea root extract (-0-0.5%), sodium hydroxide (-1.5-4%), titanium dioxide (and) mica (-0-0.9%), or a combination thereof, all amounts by weight, based on the weight of the composition.Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCT

[0033] In some embodiments, the disclosure provides a cosmetic composition that comprises a emulsion system comprising at least two emulsifiers comprising from about 5% to about 10% of the Polyglyceryl-2 Isostearate / Dimer Dilinoleate Copolymer elastomer gel, by weight, based on the weight of the composition; from about 0.5% to about 1% of Polyglyceryl-6 Polyricinoleate, by weight, based on the weight of the composition; ascorbic acid or a derivative thereof present in a range from about 5% to about 20%, by weight, based on the weight of the composition; and at least one additional ingredient selected from the group consisting of Cl 5-19 Alkane, Isoamyl Laurate, Tocopherol, Glycerin, Magnesium Sulfate, Tetrasodium Glutamate Diacetate, Pentylene Glycol, Hydroxyacetophenone, Zingiber Officinale (Ginger) Root Extract, Hydroxypropyl Tetrahydropyrantriol, Gentiana Lutea Root Extract, Sodium Hydroxide, Titanium Dioxide (And) Mica, and combinations thereof. In some embodiments, the composition is a water-in-oil emulsion comprising an oil phase and an internal water phase with a concentration of the internal water phase that is at least about 74%, by weight, based on the weight of the composition, and wherein the oil phase does not exceed 20%, by weight, based on the weight of the composition. In some embodiments, the composition demonstrates one or more of the following: (i) a viscosity in a range from about 30,000 cP to about 300,000 cP; (ii) emulsion and viscosity stability when exposed to at least ten 24-hour freeze / thaw cycles at freezing temperatures of about -20 °C and thaw temperatures of about 25 °C; (iii) stability of the ascorbic acid or derivative thereof as demonstrated by lack of precipitation and crystallization, and lack of visibly detectable color change after at least two months at ambient and elevated temperatures of about 25 °C and 45 °C, respectively; (iv) resistance to pilling or noodling on application of shear when applied to a keratinous substate at a temperature of about 25 °C; (v) when subjected to shear, the composition releases the water phase from the oil phase and melts from a thick cream to a watery liquid; and (vi) combinations thereof. In some embodiments, ascorbic acid is present in the composition in a range from about 7% to about 15%, by weight, based on the weight of the composition.

[0034] The technical advantages of the embodiments include the ability to create a stable water-in-oil emulsion that maintains desired texture and consistency without reliance on silicone, and demonstrates one or more of long-term stability and effectiveness of ascorbic acid in the formulation, benefit of transformative texture that enhances user experience, emulsion stability and texture stability, enhanced skin feel, avoidance of undesirable interactions with other formulation components, provision of effective antioxidant benefits, maintenance of desiredAttorney Docket No. OA25160-WO-PCT / 31710-7189-PCTemulsion characteristics and hydration properties, maintenance of a lightweight feel while ensuring emulsion stability, provision of optimal hydration and texture, achievement of desirable texture and ease of application, enhanced stability under extreme temperature conditions, enhanced functional and sensory properties due to additional ingredients, delivery of antioxidant benefits, effective integration of active ingredients in a stable emulsion system, compatibility with consumers seeking silicone-free products or products with reduced silicones, and comprehensive stability and performance under extreme conditions while providing effective skin benefits.

[0035] These and other aspects of the invention are set out in the appended claims, and described in greater detail in the detailed description of the invention.

[0036] It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the disclosure.DETAILED DESCRIPTION

[0037] The disclosure provides, in various embodiments, provides a cosmetic composition that comprises a emulsion system comprising at least two emulsifiers comprising crosslinked polyester elastomer; and Polyglyceryl-6 Polyricinoleate; and ascorbic acid or a derivative thereof, wherein the composition is a water-in-oil emulsion comprising an oil phase and an internal water phase with a concentration of the internal water phase that is at least about 74%, by weight, based on the weight of the composition. When subjected to shear, releases the water phase from the oil phase and melts from a thick cream to a watery liquid. The crosslinked polyester elastomer (the elastomer) comprises an elastomer selected from elastomers included in the disclosure in W02024206504A1, and in some embodiments, comprises a reaction product of:

[0038] (i) at least one di-carboxylic acid or tri-carboxylic acid; (ii) at least one monocarboxylic acid; and (iii) at least one polyol, wherein the at least one di-carboxylic acid is a compound of formula (IA)o oHer R1AOHAttorney Docket No. OA25160-WO-PCT / 31710-7189-PCT

[0039] wherein R1Ais C2-C52 alkyl group, C2-C52 heteroalkyl group, C2-C52 alkene group, C2-C52 heteroalkene group, C3-C52 cyclic group, or C2-C52 heterocyclic group,

[0040] and wherein the at least one tri-carboxylic acid is a compound of formula (IB)

[0041] wherein R1Bis C2-C52 alkyl group, C2-C52 heteroalkyl group, C2-C52 alkene group, C2-C52 heteroalkene group, C3-C52 cyclic group, or C2-C52 heterocyclic group,

[0042] and wherein the at least one mono- carboxylic acid is a compound of formula (II) oII (II)R2OH

[0043] wherein R2is C2-C52 alkyl group, C2-C52 heteroalkyl group, C2-C52 alkene group, C2-C52 heteroalkene group, C3-C52 cyclic group, or C2-C52 heterocyclic group,

[0044] and wherein the at least one polyol is a compound of formula (III)R3— OH n <r,I>

[0045] wherein R3is C3-C50 alkyl group, C3-C50 heteroalkyl group, C3-C50 alkene group, C3-C50 heteroalkene group, C3-C50 cyclic group, or C3-C50 heterocyclic group; and n is an integer from 2 to 10, and in some embodiments, comprises Polyglyceryl-2 Isostearate / Dimer Dilinoleate Copolymer.

[0046] In developing the novel formulation described herein, a primary objective was to create a composition that does not rely on silicones to achieve desirable consumer attributes such as skin feel during application in a vehicle that delivers the active, ascorbic acid. The inventive compositions utilize a bio-renewable, crosslinked polyester elastomer, in some embodiment specifically Polyglyceryl-2 Isostearate / Dimer Dilinoleate Copolymer, in combination with Polyglyceryl-6 Polyricinoleate as co-emulsifiers. This configuration results in a water-in-oil emulsion with a high concentration of internal water phase, achieving up to about 90% by weightAttorney Docket No. OA25160-WO-PCT / 31710-7189-PCTof the total composition, and generally in a range from about 74% to about 90%, or from about 75% to about 85%. Unexpectedly, these compositions exhibit a "water- breaking" sensory experience akin to that of traditional silicone elastomers, providing a stable and pleasant application feel wherein upon application of shear (rubbing) the composition converts from a rich cream and melts to a smooth watery texture. This novel sensory characteristic, combined with the composition's stability over a two-month testing period, demonstrates that the elastomer combination not only replicates the desirable qualities of silicone-containing formulations but also delivers an improved sensory experience in a more desirable carrier that does not rely on silicone elastomer, for additional consumer benefits such as ascorbic acid delivery, hydration, anti-aging, cleansing, and makeup removal. Thus, the compositions can be effectively utilized in various applications including skincare treatments, makeup removal, color cosmetics, and hair care products, delivering unexpected benefits even without the inclusion of silicones. Also, unexpectedly, the cosmetic composition demonstrates resistance to pilling or noodling, a phenomenon that is problematic and occurs in compositions that in particular lack silicones. As compared with other compositions having similar formulations, the instant cosmetic composition demonstrates minimal pilling or noodling under shear when the composition is spread on keratinous tissue, as shown in the instant examples.

[0047] The composition, can comprise, consist of, or consist essentially of the essential elements and limitations of the invention described herein, as well as any additional or optional ingredients, components, or limitations described herein or otherwise useful.

[0048] “Cosmetically acceptable” as used herein means and refers to a carrier that is compatible with any keratinous substrate.

[0049] ‘Keratinous substrate” and “keratinous tissue” each includes but is not limited to skin, hair, and nails.

[0050] Skin” as used herein means and refers to skin materials containing keratin such as facial and body skin, scalp, eyebrows, and lips.

[0051] Stable” and “Stability” as used herein means that the composition does not show any signs of significant changes in one or more of clarity, color, odor, pH, or viscosity at roomAttorney Docket No. OA25160-WO-PCT / 31710-7189-PCTtemperature and at temperatures in the range from about 25 °C to about 45 °C, remaining transparent without loss of viscosity, without haziness, and without evidence of precipitation or phase separation. In various embodiments, an inventive composition remains stable at temperatures in the range from about 25 °C to about 45 °C, over a time period of at least one month, or at least two months, or longer, or any value, range, or sub-range therebetween. In some embodiments, a composition is stable at 25 °C for at least one month, or at least two months, or longer, or any value, range, or sub-range therebetween. In some embodiments, a composition is stable at 45 °C for at least one month, or at least two months, or longer, or any value, range, or sub-range therebetween.

[0052] Viscosity was measured using a Brookfield Helipath T-F (#96) spindle with a spinning speed of 10 rpm for 1 minute at 25 °C (cP). In some embodiments, the viscosity is in the range from about 30,000 cP to about 300,000 cP. Stable inventive compositions demonstrate viscosity in a range from about 30,000 cP to about 300,000 cP. Unsatisfactory compositions are deemed unstable at viscosities that fall below about 30,000 cP, or about 20,000 cP at ambient temperature of about 25 °C and after exposure to 45 °C for after two months.

[0053] Water in Oil Emulsion Composition

[0054] The present invention relates to a cosmetic composition that is formulated as a water-in-oil emulsion. This composition includes an emulsion system, active ingredients, and additional optional components, each contributing to the unique properties and performance of the formulation. Below, each component is described in detail, including its function and contribution to the overall composition.

[0055] Emulsion system

[0056] The emulsion system in the present invention comprises an elastomer gel that comprises a crosslinked polyester elastomer and Polyglyceryl-6 Polyricinoleate. In various embodiments, the crosslinked polyester elastomer, or the elastomer, is selected from elastomers included in the disclosure in W02024206504A1, and in some embodiments, comprises a reaction product of:Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCT

[0057] (i) at least one di-carboxylic acid or tri-carboxylic acid; (ii) at least one monocarboxylic acid; and (iii) at least one polyol, wherein the at least one di-carboxylic acid is a compound of formula (IA)o oX. x (IA)HO R1AOH

[0058] wherein R1Ais C2-C52 alkyl group, C2-C52 heteroalkyl group, C2-C52 alkene group, C2-C52 heteroalkene group, C3-C52 cyclic group, or C2-C52 heterocyclic group,

[0059] and wherein the at least one tri-carboxylic acid is a compound of formula (IB)(IB)

[0060] wherein R1Bis C2-C52 alkyl group, C2-C52 heteroalkyl group, C2-C52 alkene group, C2-C52 heteroalkene group, C3-C52 cyclic group, or C2-C52 heterocyclic group,

[0061] and wherein the at least one mono- carboxylic acid is a compound of formula (II) oII (II)R2OH

[0062] wherein R2is C2-C52 alkyl group, C2-C52 heteroalkyl group, C2-C52 alkene group, C2-C52 heteroalkene group, C3-C52 cyclic group, or C2-C52 heterocyclic group,

[0063] and wherein the at least one polyol is a compound of formula (III)R3— OH n <"»

[0064] wherein R3is C3-C50 alkyl group, C3-C50 heteroalkyl group, C3-C50 alkene group, C3-C50 heteroalkene group, C3-C50 cyclic group, or C3-C50 heterocyclic group; and n is an integer from 2 to 10. In some embodiments, the elastomer comprises Polyglyceryl-2 Isostearate / Dimer Dilinoleate Copolymer. In some embodiments the elastomer gel and Polyglyceryl-6Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCTPolyricinoleate are present in a ratio of the elastomer gel to Polyglyceryl-6 Polyricinoleate that is at least about 1:1, or is 1:1, by weight, based on the weight of each ingredient. In some embodiments the elastomer gel and Polyglyceryl-6 Polyricinoleate are present in a ratio of the elastomer gel to Polyglyceryl-6 Polyricinoleate that is in a range from about 1 : 1 to about 20: 1 by weight, based on the weight of each ingredient.

[0065] In some embodiments, the composition excludes any other emulsifier. In some particular embodiments, the composition excludes an emulsifier selected from the group consisting of Polyglyceryl-4 Isostearate, Polyglyceryl-3 Diisostearate, Polyglyceryl-3 Polyricinoleate, Polyglyceryl-4 Diisostearate / Polyhydroxystearate / Sebacate (And) Caprylic / Capric Triglyceride (And) Polyglyceryl-3 Oleate (And) Diisostearoyl Polyglyceryl-3 Dimer Dilinoleate, Polyglyceryl-4 Diisostearate / Polyhydroxystearate / Sebacate, and combinations thereof. In some particular embodiments, the composition excludes each of Polyglyceryl-4 Isostearate, Polyglyceryl-3 Diisostearate, Polyglyceryl-3 Polyricinoleate, Polyglyceryl-4 Diisostearate / Polyhydroxystearate / Sebacate (And) Caprylic / Capric Triglyceride (And) Polyglyceryl-3 Oleate (And) Diisostearoyl Polyglyceryl-3 Dimer Dilinoleate, Polyglyceryl-4 Diisostearate / Polyhydroxystearate / Sebacate.

[0066] Elastomer Gel

[0067] In various embodiments, the composition includes an elastomer gel (RM), comprising from about 15% to about 30% by weight of the total composition. The elastomer gel comprises a crosslinked polyester elastomer active, as described herein, and a solvent. In some embodiments, the crosslinked polyester elastomer active is present at an active amount that constitutes about 30% of the total concentration of the elastomer gel raw material. This ensures solvation of the elastomer active.

[0068] In various embodiments, the cosmetic composition comprises from about 1% to about 10%, or from about 5% to about 10%, or from about 1% to about 5%, or from about 1% to about 3%, or from about 2% to about 8%, or from about 3% to about 7% of the elastomer gel RM comprising: (i) a crosslinked polyester elastomer active, and a combination thereof, and (ii) a solvent comprising coco-caprylate / caprate and squalane, wherein the concentration of the crosslinked polyester elastomer active in the elastomer gel is about 30%.Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCT

[0069] While the elastomer gel RM may be present in the cosmetic composition in the above recited ranges, it will be understood that the elastomer gel is present within the range from about 1% to about 10%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the cosmetic composition. One of ordinary skill in the art, however, will appreciate that other ranges are within the scope of the invention. Thus, the elastomer gel may be present by weight, based on the total weight of the cosmetic composition, from about 1, 2, 3, 4, 5, 6, 7, 8, 9 to about 10 weight percent, including increments and ranges therein and there between.

[0070] Elastomer Active

[0071] As set forth herein, the claims and specification and examples recite amounts of the elastomer gel RM present in the cosmetic composition in a range from about 1% to about 10%, or any suitable combination, sub-combination, range, or sub-range thereof, by weight, based on the weight of the cosmetic composition, wherein in some embodiments the concentration of the crosslinked polyester elastomer active in the elastomer gel is about 30%. Accordingly, 1-10% of the RM equates to an amount of the crosslinked polyester elastomer active present from about 0.3% to about 3% of the active, by weight, based on the weight of the cosmetic composition.

[0072] Thus, in various embodiments, the amount of crosslinked polyester elastomer active is present from about 0.3% to about 3%, or from about 0.2% to about 2%, or from about 0.1% to about 1%, or from about 0.5% to about 1.5%, or from about 1.5% to about 3%, or about 3%, or about 1.5%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the cosmetic composition. One of ordinary skill in the art, however, will appreciate that other ranges are within the scope of the invention. Thus, crosslinked polyester elastomer active may be present by weight, based on the total weight of the cosmetic composition, from about 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 2, 3, 4, to about 5 weight percent, including increments and ranges therein and there between.

[0073] In various embodiments, the composition includes a solvent for the elastomer active in the gel, the solvent comprising coco-caprylate / caprate and squalane. The solvent is present in concentrations ranging from about 0.7% to about 7% by weight, based on the weight of the composition.Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCT

[0074] Polyglyceryl-6 Polyricinoleate

[0075] In various embodiments, the cosmetic composition comprises Polyglyceryl-6 Polyricinoleate, present in an amount from about 0.2% to about 1%, or from about 0.5% to about 1%, or from about 0.1% to about 0.5%, or from about 0.1% to about 0.3%, or from about 0.2% to about 0.8%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the cosmetic composition. Thus, Polyglyceryl-6 Polyricinoleate may be present by weight, based on the total weight of the cosmetic composition, from about 0.1 , 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9 to about 1 weight percent, including increments and ranges therein and there between.

[0076] Reference is made to W02024206504A1, W02024206504A1 - Polyester elastomers from di-carboxylic acid or tri-carboxylic acid, mono-carboxylic acid, and polyol for cosmetic and personal care applications, which provides polyester elastomers, compositions, and methods of preparing such elastomers and compositions.

[0077] Crosslinked polyester elastomers comprise the reaction product of at least one dicarboxylic acid or tri-carboxylic acid, at least one mono-carboxylic acid, and at least one polyol. In an aspect, the polyester elastomers are prepared by an esterification reaction between at least one di-carboxylic acid or tri- carboxylic acid, at least one mono-carboxylic acid, and at least one polyol that creates a crosslinked polymer structure. The polyester elastomers can further be swollen under shear force with a low molecular weight emollient or solvent to form a uniform polyester gel or paste having a wide viscosity range. These elastomers are expected to deliver superior performance benefits such as improved sensory, structuring, and rheological performance compared to their analogous elastomers disclosed previously. In another aspect, this invention relates to a personal care composition containing such high purity polyesters elastomers.

[0078] In a first aspect, the polyester elastomer comprises the reaction product of:

[0079] (i) at least one di-carboxylic acid or tri-carboxylic acid;

[0080] (ii) at least one mono-carboxylic acid; and

[0081] (iii) at least one polyol.Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCT

[0082] In an aspect, the elastomer is prepared by reacting:

[0083] (i) at least one di-carboxylic acid of formula (IA)o o.C II. J ITI( A)Her ^R1AXJH

[0084] wherein

[0085] RIA is C2-C52 alkyl group, C2-C52 heteroalkyl group, C2-C52 alkene group, C2-C52 heteroalkene group, C3-C52 cyclic group, or C2-C52 heterocyclic group; or

[0086] at least one tri-carboxylic acid of formula (IB)(IB)

[0087] wherein

[0088] RIB is C2-C52 alkyl group, C2-C52 heteroalkyl group, C2-C52 alkene group, C2-C52 heteroalkene group, C3-C52 cyclic group, or C2-C52 heterocyclic group;

[0089] (ii) at least one mono-carboxylic acid of formula (II)oII (II)R2OHAttorney Docket No. OA25160-WO-PCT / 31710-7189-PCT

[0090] wherein

[0091] R2 is C2-C52 alkyl group, C2-C52 heteroalkyl group, C2-C52 alkene group, C2- C52 heteroalkene group, C3-C52 cyclic group, or C2-C52 heterocyclic group; and

[0092] (iii) at least one polyol of formula (III)(Hl)

[0093] wherein

[0094] R3 is C3-C50 alkyl group, C3-C50 heteroalkyl group, C3-C50 alkene group, C3-C50 heteroalkene group, C3-C50 cyclic group, or C3-C50 heterocyclic group; and

[0095] n is an integer from 2 to 10.

[0096] In an aspect, the method of preparing a polyester elastomer comprises reacting:

[0097] (i) at least one di-carboxylic acid or tri-carboxylic acid;

[0098] (ii) at least one mono-carboxylic acid; and

[0099] (iii) at least one polyol.

[0100] In an aspect, the preparation of polyester elastomer is without solvent or emollient. In an aspect, the preparation of polyester elastomer is with solvent or emollient as defined herein.

[0101] In an aspect, polyester elastomer is only comprised of polyester. In an aspect, polyester elastomer is only comprised of crosslinked polyester. In an aspect, polyester elastomer is comprised of crosslinked polyester and non-crosslinked polyester. In an aspect, polyester elastomer is comprised of polyester and solvent or emollient. In an aspect, polyester elastomer is comprised of crosslinked polyester and solvent or emollient. In an aspect, polyester elastomer is comprised of crosslinked polyester, non-crosslinked polyester, and solvent or emollient.

[0102] In an aspect, the polyester elastomer is a powder.Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCT

[0103] The polyester elastomers form crosslinked polymer networks. As is well-known to a skilled person in the art such crosslinked polymer are not (completely) soluble and certain methods are available to characterize them, including for example sol-gel analysis (determination of the gel fraction), swelling ratio analysis (determination of the swelling ratio), and mechanical analysis (e.g. determination of the modulus) (see e.g. Polym. Chem., 2024, 15, 219-247).

[0104] In an aspect, the fraction of the polyester elastomer which is not soluble in ethyl acetate (gel fraction) is greater than or equal to 20%. In an aspect, the fraction of polyester elastomer which is not soluble in ethyl acetate (gel fraction) is greater than or equal to 40%. In an aspect, the fraction of the polyester elastomer which is not soluble in ethyl acetate (gel fraction) is greater than or equal to 50%. In an aspect, the fraction of the polyester elastomer which is not soluble in ethyl acetate (gel fraction) is greater than or equal to 60%. In an aspect, the fraction of the polyester elastomer which is not soluble in ethyl acetate (gel fraction) is greater than or equal to 70%. The gel fraction is suitably defined asi;" 100 x wetflt of tfce pojy&stor elastomer used $n t / se extraction '

[0105] In an aspect, the gel fraction can be determined with an extraction method such as the Soxhlet extraction described herein.

[0106] In an aspect, polyester elastomer composition is comprised of polyester elastomer and solvent or emollient as defined herein. In an aspect, polyester elastomer composition is comprised of polyester elastomer without solvent or emollient as defined herein. In an aspect, polyester elastomer composition is gel or powder.

[0107] In an aspect, the polyester elastomer composition is a polyester elastomer combined with one or more solvents or emollients, which can be converted to a polyester elastomer gel (the swollen polyester elastomer), for example, by applying a shear force to the composition.

[0108] The term “hydrocarbon,” as used herein by itself or as part of a group, refers to a straight- or branched-chain aliphatic series of one to two hundred carbon atoms, i.e., a Cl- C200 hydrocarbon, or the number of carbon atoms designated, e.g., a Cl hydrocarbon such as a methyl, a C2 hydrocarbon such as ethyl, etc. In one embodiment, the hydrocarbon is a C2-Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCTC200 hydrocarbon group. In an embodiment, the hydrocarbon is a C6-C60 hydrocarbon group. In an embodiment, the hydrocarbon is a C6-C60 hydrocarbon group. In an embodiment, the hydrocarbon is a C2-C60 hydrocarbon group. In an embodiment, the hydrocarbon is a C5-C22 hydrocarbon group. Examples of hydrocarbon groups include butyl, octyl, decyl, lauryl, cetyl (palmityl), and stearyl.

[0109] The term “alkyl,” as used herein by itself or as part of a group, refers to a straight- or branched-chain aliphatic hydrocarbon containing one to two hundred carbon atoms, i.e., a C2-C200 alkyl, or the number of carbon atoms designated, e.g., a Cl alkyl such as methyl, a C2 alkyl such as ethyl, etc. In one embodiment, the alkyl is a C2-C200 alkyl group. In another embodiment, the alkyl is a C6-C60 alkyl group. In another embodiment, the alkyl is a C2-C60 alkyl group. In another embodiment, the alkyl is a C5-C22 alkyl group. Examples of alkyl groups include butyl, octyl, decyl, lauryl, cetyl (palmityl), and stearyl.

[0110] The term “alkene,” as used herein by itself or as part of a group, refers to an alkyl group containing one, two, three, or more carbon-to-carbon double bonds. In one embodiment, the alkene group is a C2-C200 alkylene group. In another embodiment, the alkene group is a C6-C60 alkene group. In another embodiment, the alkene group is a C2- C60 alkene group. In another embodiment, the alkene group is a C5-C22 alkene group.

[0111] The term “alkyne,” as used herein by itself or as part of a group, refers to an alkyl group containing one, two, three, or more carbon-to-carbon triple bonds. In another embodiment, the alkyne is a C2-C200 alkyne group.

[0112] The term “cyclic,” as used herein by itself or as part of a group, refers to a stable cyclic compound containing three or more atoms. In an embodiment, the cyclic is a C3- C200 cyclic group. In an embodiment, the cyclic is a C6-C60 cyclic group. In an embodiment, the cyclic is a C5-C22 cyclic group. Examples of cyclic compounds include benzene, cyclopentane, and cyclohexane.

[0113] The term “heteroalkyl,” as used herein by itself or as part of a group, refers to a stable straight or branched chain alkyl radical containing two to two hundred carbon atoms and at least one heteroatom, which can be the same or different, selected from O, N, or S, wherein the sulfurAttorney Docket No. OA25160-WO-PCT / 31710-7189-PCTatom(s) can optionally be oxidized. The heteroatoms can be placed at any interior position of the heteroalkyl group or at a position at which the heteroalkyl group is attached to the remainder of the molecule. In an embodiment, the heteroalkyl is a C6-C60 heteroalkyl group. In an embodiment, the heteroalkyl is a C2-C60 heteroalkyl group. Examples of heteroalkyl compounds include succinyl, adipoyl, and sebacoyl.

[0114] The term “heteroalkene,” as used herein by itself or as part of a group, refers to a stable straight or branched chain alkene radical containing two to two hundred carbon atoms and at least one heteroatom, which can be the same or different, selected from O, N, or S, wherein the sulfur atom(s) can optionally be oxidized. The heteroatom can be placed at any interior position of the heteroalkyl group or at a position at which the heteroalkyl group is attached to the remainder of the molecule. In an embodiment, the heteroalkene is a C6-C60 heteroalkene group. In an embodiment, the heteroalkene is a C2- C60 heteroalkene group. Examples of heteroalkene compounds include oleoyl, ricinolyl, and linoleoyl.

[0115] The term “heteroalkyne,” as used herein by itself or as part of a group, refers to a stable straight or branched chain alkyne radical containing two to two hundred carbon atoms and at least one heteroatom, which can be the same or different, selected from O, N, or S, wherein the sulfur atom(s) can optionally be oxidized. The heteroatom can be placed at any interior position of the heteroalkyl group or at a position at which the heteroalkyl group is attached to the remainder of the molecule.

[0116] The term “heterocyclic,” as used herein by itself or as part of a group, refers to a stable cyclic compound containing two or more carbons atoms and at least one heteroatom, which can be the same or different, selected from O, N, or S, wherein the sulfur atom(s) can optionally be oxidized. In an embodiment, the heterocyclic is a C2-C200 heterocyclic group. In an embodiment, the heterocyclic is a C6-C60 heterocyclic group. In an embodiment, the heterocyclic is a C5-C22 heterocyclic group. Examples of heterocyclic compounds include furan, oxolane, and thiophene.

[0117] As used herein, the term “olefin” refers to any species having at least one ethylenic double bond such as normal and branched chain aliphatic olefins, cycloaliphatic olefins, aryl substituted olefins, and the like. An olefin can comprise terminal double bond(s) ("terminalAttorney Docket No. OA25160-WO-PCT / 31710-7189-PCTolefin") and / or internal double bond(s) ("internal olefin") and can be cyclic or acyclic, linear or branched, optionally substituted. The total number of carbon atoms can be from 1 to 100, or from 1 to 40; the double bonds can be unsubstituted or mono-, bi-, tri- or tetrasubstituted.

[0118] As used herein, the term "polyolefin" refers to a homopolymer or copolymer of ethylene, propylene, butenes and other unsaturated aliphatic hydrocarbons, vinyl esters (e.g. vinyl acetate), or (meth)acrylics (e.g. butyl acrylate, acrylic acid). Generally, the polyolefin will be a polymer of ethylene, propylene or copolymer thereof, or a copolymer of ethylene or propylene with one or more C4-C12 a-olefin aliphatic comonomers.

[0119] A gel is a disperse system comprising at least two components: a solid component and a liquid component. The solid component forms a sponge-like, three-dimensional network whose pores are filled by a liquid. The liquid component is thus immobilized in the solid. In the gel of the invention the solid component is a three-dimensional network formed of the cross-linked polyester elastomer, and the liquid component is formed of one or more solvents or emollients as defined herein. A gel is a semi-solid that can have properties ranging from soft and weak to hard and tough. Gels are also defined as a substantially dilute cross-linked system.

[0120] An elastomer gel is thus made from the elastomer powders or particles swelled or dispersed in a liquid, such as a solvent or an emollient, to form a gel. The ability to swell is commonly expressed by the swelling ratio as explained herein.

[0121] II. Polyester Elastomers

[0122] In one aspect, the present disclosure is directed to an elastomer comprising the reaction product of:

[0123] (i) at least one di-carboxylic acid or tri-carboxylic acid;

[0124] (ii) at least one mono-carboxylic acid; and

[0125] (iii) at least one polyol.

[0126] In an aspect, the elastomer is a polyester elastomer. In an aspect, the elastomer is a crosslinked polyester elastomer.Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCT

[0127] In an aspect, at least one of the components (i) and / or (iii) has a functionality of > 2. In aspect, the polyol (iii) has a functionality of > 3.

[0128] In an aspect, the component (i) has a functionality of 2 (di-carboxylic acid) and the polyol (iii) has a functionality of > 3.

[0129] In an aspect, the at least one di-carboxylic acid is a compound of formula (IA)(IA)R1A

[0130] wherein

[0131] RIA is C2-C52 alkyl group, C2-C52 heteroalkyl group, C2-C52 alkene group, C2-C52 heteroalkene group, C3-C52 cyclic group, or C2-C52 heterocyclic group.

[0132] In an aspect, the di-carboxylic acid is a compound of formula (IA), wherein RIA is C4-C34 alkyl group, C4-C34 heteroalkyl group, C4-C34 alkene group, C4-C34 heteroalkene group, C4-C34 cyclic group, or C4-C34 heterocyclic group.

[0133] In an aspect, the di-carboxylic acid is a compound of formula (IA), wherein RIA is C4-C34 alkyl group.

[0134] In an aspect, the di-carboxylic acid is selected from the group consisting of succinic acid, glutaric acid, adipic acid, pimelic acid, suberic acid, azelaic acid, sebacic acid, brassylic acid, dodecanedioic acid, C21 dimer acid, C36 dimer acid, maleic acid, fumaric acid, traumatic acid, and combinations thereof. In an aspect, the di-carboxylic acid is dilinoleic acid. In an aspect, the di-carboxylic acid is a C36 dimer acid. In an aspect, the di-carboxylic acid is a hydrogenated C36 dimer acid.

[0135] In an aspect, the di-carboxylic acid is biobased or naturally derived.Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCT

[0136] 2. Tri-carboxylic Acids

[0137] In an aspect, the at least one tri-carboxylic acid is a compound of formula (IB)Rlb-C — OH (IB)

[0138] wherein

[0139] RIB is C2-C52 alkyl group, C2-C52 heteroalkyl group, C2-C52 alkene group, C2-C52 heteroalkene group, C3-C52 cyclic group, or C2-C52 heterocyclic group.

[0140] In an aspect, the tri-carboxylic acid is a compound of formula (IB), wherein RIB is C4-C34 alkyl group, C4-C34 heteroalkyl group, C4-C34 alkene group, C4-C34 heteroalkene group, C4-C34 cyclic group, or C4-C34 heterocyclic group.

[0141] In an aspect, the tri-carboxylic acid is a compound of formula (IB), wherein RIB is C4-C34 alkyl group.

[0142] In an aspect, the tri-carboxylic acid is selected from the group consisting of citric acid, C54 trimer acid, and hydrogenated C54 trimer acid. In an aspect, the tri-carboxylic acid is a C54 trimer acid.

[0143] In an aspect, the di-carboxylic acid is biobased or naturally derived.

[0144] 3. Mono-carboxylic Acids

[0145] In an aspect, the at least one mono-carboxylic acid is a compound of formula (II)(II)R2^ ^OHAttorney Docket No. OA25160-WO-PCT / 31710-7189-PCT

[0146] wherein

[0147] R2 is C2-C52 alkyl group, C2-C52 heteroalkyl group, C2-C52 alkene group, C2-C52 heteroalkene group, C3-C52 cyclic group, or C2-C52 heterocyclic group.

[0148] In an aspect, the mono-carboxylic acid is a compound is formula (II), wherein R2 is C5-C21 alkyl group, C5-C21 heteroalkyl group, C5-C21 alkene group, C5-C21 heteroalkene group, C5-C21 cyclic group, or C5-C21 heterocyclic group.

[0149] In an aspect, the mono-carboxylic acid is selected from the group consisting of caprylic acid, capric acid, lauric acid, myristic acid, palmitic acid, stearic acid, isostearic acid, behenic acid, oleic acid, linoleic acid, linolenic acid, and combinations thereof. In an aspect, the monocarboxylic acid is oleic acid. In an aspect, the mono-carboxylic acid is isostearic acid.

[0150] In an aspect, the mono-carboxylic acid is biobased or naturally derived.

[0151] 4. Polyols

[0152] In an aspect, the at least one polyol is a compound of formula (III)R3 OH] n <ni)

[0153] wherein

[0154] R3 is C3-C50 alkyl group, C3-C50 heteroalkyl group, C3-C50 alkene group, C3-C50 heteroalkene group, C3-C50 cyclic group, or C3-C50 heterocyclic group; and

[0155] n is an integer from 2 to 10.

[0156] In an aspect, the polyol is a compound of formula (III), wherein R3 is C3-C50 alkyl group, C3-C50 heteroalkyl group, C3-C50 alkene group, or C3-C50 heteroalkene group; and n is an integer from 2 to 10.

[0157] In an aspect, the polyol is a compound of formula (III), wherein R3 is C3-C20 alkyl group, C3-C20 heteroalkyl group, C3-C20 alkene group, or C3-C20 heteroalkene group; and n is an integer from 2 to 10.Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCT

[0158] In an aspect, the polyol is a compound of formula (III), wherein n is an integer from 2 to 6. In an aspect, the polyol is a compound of formula (III), wherein n is 2, 3, 4, 5, or 6. In an aspect, the polyol is a compound of formula (III), wherein n is an integer from 3 to 10. In an aspect, the polyol is a compound of formula (III), wherein n is an integer from 3 to 6.

[0159] In an aspect, the polyol is selected from the group consisting of glycerol, diglycerol, polyglycerol, polyglycerol-3, sorbitol, castor oil, hydrogenated castor oil, sugar alcohol, monosaccharide, disaccharides, oligosaccharide, polysaccharides, tannin, gallic acid, 1,2-propanediol, 1,3 -propanediol, 1 ,4-butanediol, 1 ,2-pentanediol, 1,3- pentanediol, 1,4-pentanediol, 1,5-pentanediol, 1 ,2-hexanediol, 1,5-hexanediol, 1,6- hexanediol, C36 dimer diol, hydrogenated C36 dimer diol, and combinations thereof. In an aspect, the polyol is hydrogenated castor oil. In an aspect, the polyol is diglycerol. In an aspect, the polyol is polyglycerol-3. In an aspect, the polyol is polyglycerol-4.

[0160] In an aspect, the polyol is biobased or naturally derived.

[0161] B. Ratio of Components

[0162] In an aspect, the elastomer comprises a defined molar ratio of carboxyl functional groups (-COOH) from mono-carboxylic acid to hydroxyl functional groups (-OH) from polyol. It has been found that the molar ratio of carboxyl functional groups (-COOH) from mono-carboxylic acid to hydroxyl functional groups (-OH) from the polyol influences the performance of the polyester elastomer and the performance of the gel made from the polyester elastomer.

[0163] In an aspect, the molar ratio of carboxyl functional groups (-COOH) from monocarboxylic acid to hydroxyl functional groups (-OH) from polyol is from about 1:2 to about 1:16. In an aspect, the molar ratio of carboxyl functional groups (-COOH) from mono-carboxylic acid to hydroxyl functional groups (-OH) from polyol is from about 1 :2 to about 1 : 14. In an aspect, the molar ratio of carboxyl functional groups (-COOH) from mono-carboxylic acid to hydroxyl functional groups (-OH) from polyol is from about 1 :2 to about 1 : 10. In an aspect, the molar ratio of carboxyl functional groups (-COOH) from mono-carboxylic acid to hydroxyl functional groups (-OH) from polyol is from about 1:2 to about 1:8. In an aspect, the molar ratio of carboxyl functional groups (-COOH) from mono-carboxylic acid to hydroxyl functional groups (-OH) fromAttorney Docket No. OA25160-WO-PCT / 31710-7189-PCTpolyol is from about 1:2 to about 1:5. In an aspect, the molar ratio of carboxyl functional groups (-COOH) from mono-carboxylic acid to hydroxyl functional groups (-OH) from polyol is about 1:16, about 1:15, about 1:14, about 1:13, about 1:12, about 1:11, about 1:10, about 1:9, about 1:8, about 1:7, about 1:6, about 1:5, about 1:4, about 1:3, or about 1:2.

[0164] In an aspect, the molar ratio of carboxyl functional groups (-COOH) from dicarboxylic acid or tri-carboxylic acid to hydroxyl functional groups (-OH) from polyol is from about 1.5:1 to about 1:4. In an aspect, the ratio of carboxyl functional groups (- COOH) from dicarboxylic acid or tri-carboxylic acid to hydroxyl functional groups (- OH) from polyol is from about 1.5:1 to about 1:2. In an aspect, the ratio of carboxyl functional groups (-COOH) from dicarboxylic acid or tri-carboxylic acid to hydroxyl functional groups (-OH) from polyol is from about 1.5:1 to about 1:1.5. In an aspect, the ratio of carboxyl functional groups (-COOH) from dicarboxylic acid or tri-carboxylic acid to hydroxyl functional groups (-OH) from polyol is from about 1.5:1 to about 1:1.25. In an aspect, the ratio of carboxyl functional groups (-COOH) from di-carboxylic acid or tri-carboxylic acid to hydroxyl functional groups (-OH) from polyol is about 1.5:4, about 1.5:3, about 1.5:2, about 1:1, about 1:2, about 1:3, or about 1:4.

[0165] If the mole ratio of di-carboxylic acid or tri-carboxylic acid to polyol is kept constant, the amount of mono-carboxylic acid has substantial impact on the weight percentage of crosslinked polyester in resultant polyester elastomer, and the swelling value (i.e., the swelling ratio) of the polyester elastomer in coco-caprylate / caprate. The swelling value of the polyester elastomer is an important indication of how the polyester elastomer performs in personal care formulations.

[0166] In an aspect, the conversion of carboxylic acid functional groups (-COOH) to ester functional groups (-CO(O)-) is no less than 80% by mole. The percent conversion is calculated by titration of carboxylic acid functional groups (-COOH) with 0.1 N KOH in isopropanol.

[0167] Emollient or Solvent

[0168] In an aspect, the preparation of the polyester elastomer can occur in the presence of a solvent. The solvent can also act as an emollient, preferably a cosmetic emollient. When the solvent acts also as an emollient it also provides a softening, protecting, moisturizing, and / or lubricating effect to the skin. In an aspect, the solvent or emollient is a biobased or naturally derived. In anAttorney Docket No. OA25160-WO-PCT / 31710-7189-PCTaspect, the solvent or emollient is a triglyceride solvent, a mono-ester solvent, a di-ester solvent, a citrate ester solvent, an ether solvent, a carbonate solvent, a hydrocarbon solvent, a silicone solvent, or a combination thereof.

[0169] In an aspect, the solvent is a triglyceride solvent of formula (IV)O— o cJ'L- O C) R5(IV)- CT ^R6

[0170] wherein

[0171] each R4, R5, and R6 are independently C1-C35 alkyl group, C1-C35 heteroalkyl group, C2-C35 alkene group, or C2-C35 heteroalkene group.

[0172] In an aspect, the solvent is of formula (IV), wherein R4, R5, and R6 are independently C2-C17 alkyl group or C2-C17 alkylene group.

[0173] In an aspect, the solvent is a triglyceride solvent selected from the group consisting of caprylic / capric triglyceride, triheptanoin, corn oil, soybean oil, olive oil, rape seed oil, cotton seed oil, coconut oil, almond oil, argon oil, rosehip oil, black seed oil, grape seed oil, avocado oil, apricot kernel oil, geranium oil, lavender oil, rosehip oil, macadamia oil, eucalyptus oil, safflower oil, linseed oil, sunflower oil, olive oil, canola oil, sesame oil, cottonseed oil, palm oil, rapeseed oil, tung oil, peanut oil, cuphea oil, milkweed oil, salicornia oil, castor oil, and combinations thereof. In an aspect, the triglyceride solvent is selected from the group consisting of caprylic / capric triglyceride, triheptanoin, and combinations thereof.

[0174] In an aspect, the solvent is a mono-ester solvent of formula (V)Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCTo(V)R7^0 - R8

[0175] wherein

[0176] R7 is C1-C35 alkyl group, C1-C35 heteroalkyl group, C2-C35 alkene group, or C2-C35 heteroalkene group; and

[0177] R8 is C1-C35 alkyl group, C1-C35 heteroalkyl group, C2-C35 alkene group, or C2-C35 heteroalkene group.

[0178] In an aspect, the solvent is a mono-ester solvent of formula (V), wherein R7 is C5- Cl 7 alkyl group or C5-C17 alkene group and R8 is C2-C17 alkyl group or C2-C17 alkene group.

[0179] In an aspect, the solvent is a mono-ester solvent selected from the group consisting of coco-caprylate, coco-caprate, jojoba oil, jojoba esters, isopropyl jojobate, ethyl macadamiate, isoamyl laurate, heptyl undecylenate, methylheptyl isostearate, isostearyl isostearate, glyceryl ricinoleate, isostearyl palmitate, myristyl myristate, octyldodecyl myristate, octyldodecyl hydroxystearate, butyl myristate, ethylhexyl cocoate, ethylhexyl palmitate, ethylhexyl stearate, butyl stearate, decyl oleate, isocetyl behenate, isocetyl myristate, isocetyl palmitate, isocetyl stearate, isodecyl oleate, isopropyl isostearate, isopropyl myristate, isopropyl palmitate, oleyl oleate, propylene glycol laurate, octyldodecyl erucate, C12-C13 alkyl lactate, C12-C15 alkyl lactate, isostearyl lactate, glycereth-5-lactate, lauryl lactate, myristyl lactate, oleyl lactate, laureth-2- benzoate, C12-C15 alkyl benzoate, C12-C15 pareth-3 -benzoate, dipropylene glycol benzoate, isodecyl salicylate, C12-C15 alkyl salicylate, tri decyl salicylate, ethylhexyl isononanoate, cetyl ethylhexanoate, isononyl isononanoate, isodecyl ethylhexanoate, isodecyl isononanoate, tridecyl ethylhexanoate, isotridecyl isononanoate, isostearyl isononanoate, cetearyl isononanoate, laureth-2-ethylhexanoate, cetearyl ethylhexanoate, isodecyl neopentanoate, isostearyl neopentanoate, nyristyl neopentanoate, isostearyl behenate, octyldodecyl neopentanoate, tridecyl neopentanoate, and combinations thereof. In an aspect, the mono-ester solvent is selected from the group consisting of coco- caprylate / caprate, coco-caprylate, jojoba oil, isoamyl laurate, methylheptylAttorney Docket No. OA25160-WO-PCT / 31710-7189-PCTisostearate, C12-C13 alkyl lactate, C12-C15 alkyl lactate, lauryl lactate, ethylhexyl isononanoate, cetyl ethylhexanoate, isononyl isononanoate, isodecyl ethylhexanoate, isodecyl isononanoate, tridecyl ethylhexanoate, isotridecyl isononanoate, isostearyl isononanoate, cetearyl isononanoate, and combinations thereof. In an aspect, the mono-ester solvent is selected from the group consisting of coco-caprylate / caprate, coco-caprylate, isoamyl laurate, isononyl isononanoate, heptyl undecylenate, jojoba oil, jojoba esters, and combinations thereof.

[0180] In an aspect, the solvent is:

[0181] (a) a di-ester solvent of formula (VI)

[0182] wherein

[0183] R9 is C1-C35 alkyl group, C1-C35 heteroalkyl group, C2-C35 alkene group, or C2- C35 heteroalkene group; and

[0184] R10 and Rll are independently C1-C35 alkyl group, C1-C35 heteroalkyl group, C2- C35 alkene group, or C2-C35 heteroalkene group; or

[0185] (b) a di-ester solvent of formula (VII)o o(VII)

[0186] whereinAttorney Docket No. OA25160-WO-PCT / 31710-7189-PCT

[0187] R9 is C1-C35 alkyl group, C1-C35 heteroalkyl group, C2-C35 alkene group, or C2-C35 heteroalkene group; and

[0188] RIO and Rll are independently H, C1-C35 alkyl group, C1-C35 heteroalkyl group, C2-C35 alkene group, or C2-C35 heteroalkene group; or

[0189] (c) a di-ester solvent of formula (VIII)R11(VIII)o

[0190] wherein

[0191] R9 and R10 are independently C1-C35 alkyl group, C1-C35 heteroalkyl group, C2-C35 alkene group, or C2-C35 heteroalkene group; and

[0192] Rll is H, C1-C35 alkyl group, C1-C35 heteroalkyl group, C2-C35 alkene group, or C2-C35 heteroalkene group.

[0193] In an aspect, the solvent is a di-ester solvent of formula (VI), formula (VII), or formula (VIII), wherein Rll is C2-C10 alkyl group or C2-C10 alkene group and R9 and R10 are independently Cl -Cl 2 alkyl group or C2-C12 alkene group.

[0194] In an aspect, the di-ester solvent is selected from the group consisting of diethyl succinate, dibutyl succinate, diethyhexyl succinate, diisopropyl sebacate, dimethyl sebacate, diethyl sebacate, dibutyl sebacate, diisostearyl dimer, diisostearyl malate, isostearyl stearoyl stearate, isocetyl stearoyl stearate, octyldodecyl stearoyl stearate, diethylhexyl malate, diethylhexyl maleate, dipropylene glycol dibenzoate, dicapryl adipate, dicaprylyl maleate, diisopropyl dimer, diisopropyl adipate, diisobutyl adipate, diisopropyl sebacate, diisostearyl dimer, diethyhexyl succinate, diethylene glycol diethylhexanoate, neopentyl glycol dicaprate,Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCTpropylene glycol dicaprylate / dicaprate, neopentyl glycol diisostearate, neopentyl glycol diethylhexanoate, neopentyl glycol diheptanoate, and combinations thereof. In an aspect, the diester solvent is selected from the group consisting of dicapryl adipate, dicaprylyl maleate, diisopropyl adipate, diisobutyl adipate, diethyl succinate, dibutyl succinate, diethyhexyl succinate, diisopropyl sebacate, dimethyl sebacate, diethyl sebacate, dibutyl sebacate, neopentyl glycol diethylhexanoate, neopentyl glycol diheptanoate, and combinations thereof.

[0195] In an aspect, the solvent is a citrate ester solvent of formula (IX)R13

[0196] wherein

[0197] R12, R13, R14, andR15 are independently H, C1-C35 alkyl group, C1-C35 heteroalkyl group, C2-C35 alkene group, or C2-C35 heteroalkene group, wherein at least one of R12, R13, R14, and R15 is not H.

[0198] In an aspect, the solvent is a citrate ester solvent of formula (IX), wherein R12, R13, and R14 are independently C1-C10 alkyl group or C2-C10 alkene group and R15 is an acetyl group.

[0199] In an aspect, the solvent is a citrate ester solvent selected from the group consisting of tricaprylyl citrate, triisostearyl citrate, triisocetyl citrate, trioctyldodecyl citrate, triethyl citrate, tributyl citrate, acetyl triethyl citrate, acetyl tributyl citrate, trioctyldodecyl citrate, triisocetyl citrate, and combinations thereof.

[0200] In an aspect, the solvent is an ether solvent of formula (X)R1® .R17(X)OAttorney Docket No. OA25160-WO-PCT / 31710-7189-PCT

[0201] wherein

[0202] R16 and R17 are independently H, C2-C20 alkyl group, C2-C20 heteroalkyl group, C2-C20 alkene group, or C2-C20 heteroalkene group, wherein at least one of R16 and R17 is not H.

[0203] In an aspect, the solvent is an ether solvent of formula (X), wherein R16 and R17 are independently C2-C20 alkyl group.

[0204] In an aspect, the solvent is an ether solvent selected from the group consisting of dicaprylyl ether, didecyl ether, panthenyl ethyl ether, dicetyl ether, dimyristyl ether, distearyl ether, dilauryl ether, and combinations thereof. In an aspect, the ether solvent is selected from the group consisting of dicaprylyl ether, didecyl ether, and combinations thereof.

[0205] In an aspect, the solvent is a carbonate solvent of formula (XI)OR\9 (XI)

[0206] wherein

[0207] R18, and R19 are independently H, C2-C20 alkyl group, C2-C20 heteroalkyl group, C2-C20 alkene group, or C2-C20 heteroalkene group.

[0208] In an aspect, the solvent is a carbonate solvent of formula (XI), wherein R18 and R19 are independently C2-C20 alkyl group.

[0209] In an aspect, the solvent is a carbonate solvent selected from the group consisting of dicaprylyl carbonate, diethyl hexyl carbonate, and combinations thereof.

[0210] In an aspect, the solvent is a hydrocarbon with number of carbon atoms from C4 to C60. In an aspect, the solvent is a hydrocarbon with a number of carbon atoms from CIO to C50. In an aspect, the solvent is a hydrocarbon with a number of carbon atoms from C20 to C40.Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCT

[0211] In an aspect, the solvent is a hydrocarbon solvent selected from the group consisting of farnesene, hydrogenated farnesene, coconut alkanes, coconut / palm kernel alkanes, C9-C12 alkane, Cl 0-C 13 alkane, C12-C 17 alkane, Cl 3 -Cl 4 alkane, C13-C15 alkane, C14-C17 alkane, C14-C19 alkane, C14-C20 alkane, C14-C22 alkane, C15-C 19 alkane, C21-C28 alkane, C17-C23 alkane, C9-C12 isoalkane, C9-C13 isoalkane, C9-C14 isoalkane, C9-C16 isoalkane, C10-C11 isoalkane, Cl 0-C 12 isoalkane, Cl 0-C 13 isoalkane, Cl 1 -Cl 2 isoalkane, Cl 1- Cl 3 isoalkane, Cll-C14 isoalkane, C12-C14 isoalkane, C12-C15 isoalkane, C12-C20 isoalkane, C13-C14 isoalkane, C13-C16 isoalkane, C14-C16 isoalkane, C15-C19 isoalkane, C10-C16 olefin, C12-C18 olefin, C18-C26 olefin, C20 olefin, C20-C24 olefin, C24-C30 olefin, C26-C28 olefin, C26- C54 olefin, C28-C36 olefin, C28-C52 olefin, C30-C38 olefin, C30-C45 olefin, C4-C12 olefin, C4- C6 olefin, C5-C6 olefin, hydrogenated poly(C6 / C 10 / C 14 olefin), hydrogenated poly(C6-C 12 olefin), hydrogenated poly(C6-C14 olefin), hydrogenated poly(C6-C20 olefin), hydrogenated poly(C8 / Cl 2 olefin), poly(C20-C28 olefin), poly(C30-C45 olefin), poly(C4-C 12 olefin), poly(C6-C14 olefin), hexadecene, C32 alkane, C32 isoalkane, C54 alkane, C54 isoalkane, diethylhexylcyclohexane, undecane, tridecane, tetradecane, pentadecane, hexadecane, octadecane, docosane, squalane, hydrogenated polyisobutene, polybutene, hydrogenated polydecene, hydrogenated didecene, mineral oil, liquidum, petrolatum, dodecane, isohexadecane, isododecane, isoeicosane, and combinations thereof. In an aspect, the hydrocarbon solvent is selected from the group consisting of squalane, farnesene, hydrogenated farnesene, coconut alkanes, C9-C12 alkane, C13-C15 alkane, C14- C19 alkane, C14-C20 alkane, C14-C22 alkane, C15-C19 alkane, C13-C16 isoalkane, dodecane, undecane, tridecane, tetradecane, pentadecane, hexadecane, hexadecene, octadecane, squalane, isododecane, isohexadecane, C32 alkane, C32 isoalkane, C54 alkane, C54 isoalkane, and combinations thereof. In an aspect, the hydrocarbon solvent is selected from the group consisting of squalane, hydrogenated farnesene, coconut alkanes, C9-C12 alkane, Cl 3-C15 alkane, C13-C 16 isoalkane, C14-C19 alkane, dodecane, tetradecane, isododecane, hexadecane, octadecane, hexadecene, C32 alkane, C32 isoalkane, C54 alkane, C54 isoalkane, and combinations thereof.

[0212] In an aspect, the hydrocarbon solvent is selected from the group consisting of squalane, C32 alkane, C32 isoalkane, C54 alkane, C54 isoalkane, and combinations thereof.Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCT

[0213] In an aspect, a defined amount of solvent is used in the preparation of the polyester elastomer. In an aspect, the amount of solvent is from 0% to 70% of the total weight of dicarboxylic acid or tri-carboxylic acid (A), mono-carboxylic acid (B), and polyol (C). In an aspect, the amount of solvent is from 0% to 50% of the total weight of di-carboxylic acid or tri-carboxylic acid (A), mono-carboxylic acid (B), and polyol (C). In an aspect, the amount of solvent is from 0% to 40% of the total weight of di-carboxylic acid or tri-carboxylic acid (A), mono-carboxylic acid (B), and polyol (C). In an aspect, the amount of solvent is from 0% to 30% of the total weight of di-carboxylic acid or tri- carboxylic acid (A), mono-carboxylic acid (B), and polyol (C). In an aspect, the range of solvent is from 0% to 20% of the total weight of di-carboxylic acid or tricarboxylic acid (A), mono-carboxylic acid (B), and polyol (C). In an aspect, the amount of solvent is from 10% to 50% of the total weight of di-carboxylic acid or tri-carboxylic acid (A), monocarboxylic acid (B), and polyol (C). In an aspect, the amount solvent is 50%, 40%, 30%, 20%, or 10% of the total weight of di-carboxylic acid or tri-carboxylic acid (A), mono-carboxylic acid (B), and polyol (C).

[0214] In an aspect, the amount of solvent is from 0% to 30% of the total weight of di-carboxylic acid or tri-carboxylic acid (A) and mono-carboxylic acid (B). In an aspect, the amount of solvent is from 0% to 20% of the total weight of di-carboxylic acid or tri- carboxylic acid (A) and mono-carboxylic acid (B). In an aspect, the amount of solvent is from 0% to 10% of the total weight of di-carboxylic acid or tri-carboxylic acid (A) and mono-carboxylic acid (B). In an aspect, the amount of solvent is from 10% to 30% of the total weight of di-carboxylic acid or tri-carboxylic acid (A) and mono-carboxylic acid (B). In an aspect, the solvent is 30%, 20%, or 10% of the total weight of di-carboxylic acid or tri-carboxylic acid (A) and mono-carboxylic acid (B).

[0215] In an aspect, no solvent is used to prepare the elastomer.

[0216] In an aspect, a solvent is used to prepare the polyester elastomer, which is removed after preparing the polyester elastomer to form a polyester elastomer powder. In an aspect, to the polyester elastomer powder a solvent / emollient can be added again to form a polyester elastomer gel, optionally applying a shear force as described below.

[0217] In an aspect, polyester elastomer is made from C36 dimer acid, diglycerol, and isostearic acid with about 10% to about 40% by weight squalane based on the total weight of theAttorney Docket No. OA25160-WO-PCT / 31710-7189-PCTpolyester elastomer and the squalane. That is, in an aspect the invention relates to a composition of a polyester elastomer made from C36 dimer acid, diglycerol, isostearic acid, and squalane, comprising about 10% to about 40% by weight squalane.

[0218] In an aspect, polyester elastomer is made from hydrogenated C36 dimer acid, diglycerol, and oleic acid without any solvent or emollient.

[0219] In a preferred embodiment, the elastomer used according to the invention, named INCI COCO-CAPRYLATE / CAPRATE (and) POLYGLYCERYL-2 ISOSTEARATE / DIMER DILINOLEATE COPOLYMER (and) SQUALANE, is available from the company Momentive under the name Harmonie NatuVel Gel™.

[0220] Active Ingredient: Ascorbic Acid (Vitamin C)

[0221] In various embodiments, the composition comprises as an active ingredient, ascorbic acid or one of its derivatives. Accordingly, the active may be selected from Lascorbic acid, acetyl-C, 3-O-Ethyl ascorbic acid, magnesium ascorbyl phosphate, ascorbyl palmitate, ascorbyl tetra-isopalmitate, ascorbyl glucoside, ascorbyl 2-phosphate 6-palmitate, sodium ascorbyl phosphate, tetrahexyldecyl ascorbate, or a combination thereof. Ascorbic acid may be provided by the addition of any reducing analog of ascorbic acid, such as D-isoascorbic acid or by the addition of other small reducing compounds such as, but not limited to, glutathione, L-cysteamine, and the like. Such forms would be expected to provide an equivalent composition to that claimed and are within the scope of the invention.

[0222] In various embodiments, the concentration of ascorbic acid or a derivative thereof is from about 5% to about 20%, or from about 7% to about 15%, or from about 5% to about 10%, or from about 6% to about 14%, or from about 8% to about 13%, or about 15%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the cosmetic composition. One of ordinary skill in the art, however, will appreciate that other ranges are within the scope of the invention. Thus, ascorbic acid may be present by weight, based on the total weight of the cosmetic composition, from about 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 to about 15 weight percent, including increments and ranges therein and there between.Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCT

[0223] The ascorbic acid not only provides antioxidant benefits but also aids in skin brightening and rejuvenation. In some instances, its concentration is calibrated to ensure maximum efficacy while maintaining stability within the emulsion matrix. The high amount of this ingredient allows for enhanced efficacy, and its stabilization in the water phase enhances its availability for positive skin effects.

[0224] Water Phase and Oil Phase

[0225] The cosmetic composition is characterized as a water-in-oil emulsion with a substantial internal water phase. In various embodiments, the internal water phase constitutes from about 74% to about 90%, or from about 74% to about 89%, or from about 74% to about 85%, or from about 74% to about 90%, or from about 80% to about 85%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the cosmetic composition. Thus, the internal water phase may be present by weight, based on the total weight of the cosmetic composition, from about 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, to about 90 weight percent, including increments and ranges therein and there between.

[0226] The oil phase is limited to not exceeding 20%, contributing to the lightweight and non-greasy feel of the emulsion. This balance between water and oil phases is optimized to deliver hydration while ensuring the emulsion's stability and texture and ideal preservation of ascorbic acid stability. The high water content provides a pleasing transition and refreshing and moisturizing effect upon application, enhancing the user experience.

[0227] Water

[0228] In the various embodiments, the composition includes water.

[0229] In various embodiments, the composition comprises from about 40% to about 80% water, and in some embodiments, from about 50% to about 80% water, from about 60% to about 75% water, and in some embodiments, from about 55% to about 74% water, including increments and all ranges and subranges therein and there between, by weight, based on the total weight of the composition. One of ordinary skill in the art, however, will appreciate that other ranges are within the scope of the invention. Thus, water is present, by weight, based on the total weight ofAttorney Docket No. OA25160-WO-PCT / 31710-7189-PCTthe composition, from about 40, 45, 50, 55, 60, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, to about 80 weight percent, including increments and all ranges and subranges therein and there between.

[0230] The water used in the composition may be sterile demineralized water and / or a floral water such as rose water, cornflower water, chamomile water or lime water, and / or a natural thermal or mineral water such as, for example: water from Vittel, water from the Vichy basin, water from Uriage, water from La Roche Posay, water from La Bourboule, water from Enghien-les-Bains, water from Saint Gervais-les-Bains, water from Neris-les-Bains, water from Allevar-les-Bains, water from Digne, water from Maizieres, water from Neyrac-les-Bains, water from Lons-le-Saunier, water from Eaux Bonnes, water from Rochefort, water from Saint Christau, water from Les Fumades, water from Tercis-les-Bains or water from Avene. The water phase may also comprise reconstituted thermal water, that is to say a water comprising trace elements such as zinc, copper, magnesium, etc., reconstituting the characteristics of a thermal water.

[0231] Additional Ingredients

[0232] In addition to the foregoing, the composition may also incorporate various additional ingredients.

[0233] In some embodiments, the composition may include or exclude one or more of other additional ingredients (also referred to as an additive or active) selected from the group consisting of skin care actives, essential oils, moisturizing agents, vitamins, vitamin derivatives, peptides, proteins, ceramides, antioxidants, agents for combating free radicals, botanical extracts, organic UV agents, inorganic UV agents, water based solvents, oil based solvents, humectants, conditioning agents, thickeners, viscosity adjusters, cooling agents, film formers, coloring agents (e.g., dyes and pigments), waxes, thixotropic agents (e.g., clays), fragrances, fillers, fibers antimicrobials, preservatives, pH adjusters, chelating agents, surfactants (anionic, amphoteric, cationic, nonionic), emulsifiers, oils, spreading agents, dispersing agents, antifoaming agents, neutralizing agents, stabilizing agents, wetting agents, and combinations thereof, wherein the one or more of other optional additional ingredients is commonly used in cosmetic compositions and known to a person skilled in the art as being capable of being incorporated into such compositions, and does not adversely affect the properties of the composition according to the invention.Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCT

[0234] In some embodiments, the composition may also include additional ingredients to enhance its properties and consumer appeal. These ingredients may include Cl 5-19 Alkanes, Isoamyl Laurate, Tocopherol, Glycerin, Magnesium Sulfate, Tetrasodium Glutamate Diacetate, Pentylene Glycol, Hydroxyacetophenone, Zingiber Officinale (Ginger) Root Extract, Hydroxypropyl Tetrahydropyrantriol, Gentiana Lutea Root Extract, Sodium Hydroxide, Titanium Dioxide, and Mica.

[0235] In some particular embodiments, the composition comprises additional ingredients selected from Cl 5-19 alkane, isoamyl laurate, tocopherol, glycerin, magnesium sulfate, tetrasodium glutamate diacetate, pentylene glycol, hydroxyacetophenone, zingiber officinale (ginger) root extract, hydroxypropyl tetrahydropyrantriol, gentiana lutea root extract, sodium hydroxide, titanium dioxide (and) mica, or combinations thereof are present.

[0236] In some particular embodiments, the composition comprises additional ingredients that include Cl 5-19 alkane (-3%), isoamyl laurate (-2%), tocopherol (-0-1%), glycerin (-7%), magnesium sulfate (-2%), tetrasodium glutamate diacetate (-0.3%), pentylene glycol (-3%), hydroxyacetophenone (-0.5%), zingiber officinale (ginger) root extract (-0-0.1%), hydroxypropyl tetrahydropyrantriol (-0-4%), gentiana lutea root extract (-0-0.5%), sodium hydroxide (-1.5-4%), titanium dioxide (and) mica (-0-0.9%), or a combination thereof, all amounts by weight, based on the weight of the composition.

[0237] In various embodiments, the additional ingredients are present in amounts ranging from about 0.05% to about 5%, or from about 0.1% to about 3%, or from about 0.5% to about 2%, or from about 0.1% to about 1%, or from about 1% to about 4%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the cosmetic composition. Thus, additional ingredients may be present by weight, based on the total weight of the cosmetic composition, from about 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 1, 2, 3, 4 to about 5 weight percent, including increments and ranges therein and there between. These ingredients enhance the functional and sensory attributes of the composition, providing additional benefits such as moisturization, preservation, and aesthetic appeal.

[0238] Although the aforementioned optional components are given as an example, it will be appreciated that other optional components compatible with cosmetic applications known in theAttorney Docket No. OA25160-WO-PCT / 31710-7189-PCTart may be used. In some embodiments, the composition includes or excludes one or more additive selected from water soluble solvents, oils, preservatives, as well as fragrances, pH adjusters (citric acid, sodium chloride, lactic acid); neutralizing or pH-adjusting agents (e.g., triethylamine (TEA) and sodium hydroxide, Trisodium ethylenediamine disuccinate, and combinations thereof), other cosmetically acceptable additives, such as but not limited to, pearlescent agents, silica, and coloring materials; essential oils; botanical extracts, for example but not limited to, fruit extracts, for example, Pyrus Malus (Apple) Fruit Extract, dandelion extract, baicalin (Scutellaria Baicalensis root extract), pine bark extract (Pinus Pinaster bark / bud extract), and Aloe Barbadensis Leaf Juice Powder; actives (for example, hydroxy acetophenone); vitamins vitamin derivatives (for example, calcium pantothenate, vitamin A, beta carotene, tocopherol / vitamin E, panthenol, retinol), carnosine, adenosine, polydatin, orizano, resveratrol, niacinamide, derivatives thereof, and combinations thereof); hyaluronic acid in the form of hydrolyzed hyaluronic acid or sodium hyaluronate; coloring materials / pigments; essential oils; antioxidants (phenolic compounds, such as chaicones, flavones, flavanones, flavanols, flavonols, dihydroflavonols, isoflavonoids, neoflavonoids, catechins, anthocyanidins, tannins, lignans, aurones, stilbenoids, curcuminoids, alkylphenols, betacyanins, capsacinoids, hydroxybenzoketones, methoxyphenols, naphthoquinones, and phenolic terpenes, resveratrol, curcumin, pinoresinol, ferulic acid, hydroxytyrosol, cinnamic acid, caffeic acid, p-coumaric acid, ellagic acid); hydroxy acids; citric acid, sodium citrate, sodium chloride; neutralizing, chelating or pH-adjusting agents (for example, triethylamine (TEA), trisodium ethylenediamine disuccinate, EDTA, and sodium hydroxide); powders, fragrances, dyes, pigments; organic or mineral UV filters; cooling agents such as menthol; fillers, for example Kaolin; or any combination thereof.

[0239] In the various embodiments, the amount of one or more additives, alone or in combination, present in the composition can be present in a range from about 0.0001% to about 20%, and in some embodiments, from about 0.005% to about 0.01%, and in some embodiments, from about 0.01% to about 0.1%, and in some embodiments, from about 0.15% to about 5%, and in some embodiments, from about 0.40% to about 4%, and in some embodiments, from about 0.5% to about 2.5%, and in some embodiments, from about 0.1% to about 0.5% and in some embodiments, from about 1% to about 2%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the total weight of the composition. One of ordinary skill in the art, however, will appreciate that other ranges are within the scope of the invention.Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCT

[0240] Thus, any one or a combination of additional ingredients may be present, by weight, based on the total weight of the composition, each one or the combination present from about 0.0001, 0.0005, 0.001, 0.002, 0.003, 0.004, 0.005, 0.006, 0.007, 0.008, 0.009, 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 0.10, 0.20, 0.30, 0.40, 0.50, 0.60, 0.70, 0.80, 0.90, 1.0, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 to about 20 weight percent, including increments and ranges therein and there between.

[0241] Water-Soluble Solvents

[0242] In some embodiments, the composition may include as additional ingredients at least one water-soluble solvent. The term "water-soluble solvent" is interchangeable with the term “water-miscible solvent” and means a compound that is liquid at 25 °C and at atmospheric pressure (760 mmHg), and it has a solubility of at least 50% in water under these conditions. In some cases, the water-soluble solvent has a solubility of at least 60%, 70%, 80%, or 90% in water under these conditions. Non-limiting examples of water-soluble solvents include, for example, glycerin, alcohols (for example, C1-C30, C1-C15, C1-C10, or C1-C4 alcohols), polyols, glycols, and combinations thereof.

[0243] As examples of organic solvents, non-limiting mentions can be made of monoalcohols and polyols such as ethyl alcohol, isopropyl alcohol, propyl alcohol, benzyl alcohol, and phenylethyl alcohol, or glycols or glycol ethers such as, for example, monomethyl, monoethyl and monobutyl ethers of ethylene glycol, propylene glycol or ethers thereof such as, for example, monomethyl ether of propylene glycol, butylene glycol, hexylene glycol, dipropylene glycol as well as alkyl ethers of diethylene glycol, for example monoethyl ether or monobutyl ether of diethylene glycol. Other suitable examples of organic solvents are ethylene glycol, propylene glycol, butylene glycol, hexylene glycol, propane diol, and glycerin. The organic solvents can be volatile or non-volatile compounds.

[0244] Further non-limiting examples of water-soluble solvents include alkanols (polyhydric alcohols such as glycols and polyols) such as glycerin, 1,2,6-hexanetriol, trimethylolpropane, ethylene glycol, propylene glycol, diethylene glycol, butylene glycol, hexylene glycol, triethylene glycol, tetraethylene glycol, pentaethylene glycol, dipropylene glycol, 1,3 -butanediol, 2,3 -butanediol, 1 ,4-butanediol, 3 -methyl- 1,3 -butanediol, 1,5 -pentanediol, tetraethylene glycol,Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCT1,6-hexanediol, 2-methyl-2,4-pentanediol, polyethylene glycol, 1,2,4-butanetriol, 1,2,6-hexanetriol, 2-butene-l,4-diol, 2-ethyl-l,3-hexanediol, 2-methyl-2,4-pentanediol, (caprylyl glycol), 1,2-hexanediol, 1,2-pentanediol, and 4-methyl-l,2-pentanediol; alkyl alcohols having 1 to 4 carbon atoms such as ethanol, methanol, butanol, propanol, and isopropanol; glycol ethers such as ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol monobutyl ether, ethylene glycol monomethyl ether acetate, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol mono-n-propyl ether, ethylene glycol mono-iso-propyl ether, diethylene glycol mono-iso-propyl ether, ethylene glycol mono-n-butyl ether, ethylene glycol mono-t-butyl ether, di ethylene glycol mono-t- butyl ether, 1 -methyl- 1-methoxybutanol, propylene glycol monomethyl ether, propylene glycol monoethyl ether, propylene glycol mono-t-butyl ether, propylene glycol mono-n-propyl ether, propylene glycol mono-iso-propyl ether, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol mono-n-propyl ether, and dipropylene glycol mono-iso-propyl ether; 2-pyrrolidone, N-methyl-2-pyrrolidone, l,3-dimethyl-2-imidazolidinone, formamide, acetamide, dimethyl sulfoxide, sorbit, sorbitan, acetine, diacetine, triacetine, sulfolane, and combinations thereof.

[0245] In some cases, a water-soluble solvent may be selected from the group consisting of pentylene glycol, glycerin, and combinations thereof.

[0246] In the various embodiments total amount of the at least one water-soluble solvent, when present, may vary, is from about 0.5% to about 25%, or from about 0.5% to about 20%, or from about 1% to about 20%, or from about 1% to about 10%, or from about 2% to about 5% or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the weight of the composition. One of ordinary skill in the art, however, will appreciate that other ranges are within the scope of the invention.

[0247] Thus, any one water-soluble solvent, when present, is present, by weight, based on the total weight of the composition, from about 0.5, 0.6, 0.7, 0.8, 0.9, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24 to about 25 weight percent, including increments and ranges therein and there between.Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCT

[0248] The pH of the composition is not limited but is generally from 2 and 12, and in some embodiments, is one of from 3 and 11, and from 4 and 9, and from 4.5 and 6, and in some embodiments, is about pH 5.

[0249] The pH can be adjusted to the desired value by addition of a base (organic or inorganic) to the composition, for example ammonia or a primary, secondary or tertiary (poly)amine, such as monoethanolamine, diethanolamine, triethanolamine, isopropanolamine or 1,3-propanediamine, or alternatively by addition of an inorganic or organic acid, advantageously a carboxylic acid, such as, for example, citric acid.

[0250] In some embodiments, the composition excludes alcohols, for example, monoalcohols such as monohydric Ci-Cs alcohols such as ethanol, propanol, butanol, isopropanol, isobutanol, and benzyl alcohol, and phenylethyl alcohol.

[0251] Humectants

[0252] In some embodiments, the composition may include as additional ingredients one or more humectants. Thus, the composition may include or exclude one or more additional humectants. Additives may also include humectants selected from glycerin, glycerol, butylene glycol, propylene glycol / propanediol, isoprene glycol, dipropylene glycol, hexylene glycol and polyethylene glycols, monoethylene glycol, diethylene glycol, triethylene glycol, diethylene glycol, hexylene glycol, glycol ethers such as monopropylene, dipropylene and tripropylene glycol alkyl(Cl-C4)ethers, squalane, triacetin, sugars, such as glucose, xylitol, maltitol, sorbitol, sucrose pentaerythritol, inositol, pyrrolidone carboxylic acid, lactic acid, lithium chloride, acetamide MEA, sodium lactate, urea, dicyanamide, hyaluronic acid, aloe vera, honey, seaweed extract, or combinations thereof.

[0253] Oils

[0254] In some embodiments, the composition may include as additional ingredients one or more oils. Thus, the composition may include or exclude one or more additional oils that are not otherwise described in the embodiments of the inventive composition. In some embodiments, the oil is generally immiscible in water. The oil may include one or a combination of polar and nonpolar oil. The oil may be chosen from hydrocarbon-based oils from plants or of plant origin, mineral oil, silicones, fluoro oils, ester oils, fatty alcohols containing from 12 to 26 carbon atoms,Atorney Docket No. OA25160-WO-PCT / 31710-7189-PCTfaty acids containing from 12 to 26 carbon atoms and vinylpyrrolidone copolymers, and combinations thereof. As used herein, oil refers to any nonpolar compound that is a liquid at 25 °C and is hydrophobic and lipophilic. Oil that is suitable for use herein may be volatile or nonvolatile. The term "volatile oil" relates to oil that is capable of evaporating on contact with the skin or a keratin fiber in less than one hour, at room temperature and atmospheric pressure. The volatile oil(s) are liquid at room temperature and have a non-zero vapor pressure, at room temperature and atmospheric pressure, ranging in particular from 0.13 Pa to 40 000 Pa (10-3 to 300 mmHg). The term "non-volatile oil" relates to oil which remains on the skin or the keratin fiber, at room temperature and atmospheric pressure, for at least several hours and which in particular has a vapor pressure of less than 10-3 mmHg (0.13 Pa). The term "silicone oil" relates to oil comprising at least one silicon atom, and especially at least one Si-0 group. The term "fluoro oil" relates to oil comprising at least one fluorine atom. The term "hydrocarbon- based oil" relates to oil comprising mainly hydrogen and carbon atoms. Hydrocarbon-based oil may be animal hydrocarbon-based oil, plant hydrocarbon-based oil, mineral hydrocarbon-based oil or a synthetic hydrocarbon-based oil. Further, suitable oil may be a mineral hydrocarbon-based oil, a plant hydrocarbon-based oil, or a synthetic hydrocarbon- based oil.

[0255] In some examples, the oils may be chosen from hydrocarbon-based oils. For example, the hydrocarbon-based oil may be a saturated hydrocarbon, an unsaturated hydrocarbon, lipids, triglycerides, a natural oil, and / or a synthetic oil. In some embodiments, the composition may include a synthetic oil selected from the group consisting of hydrogenated polyisobutene and hydrogenated polydecene. A hydrocarbon-based oil may be a non-volatile hydrocarbon-based, such as:

[0256] (i) hydrocarbon-based oils of plant origin, such as glyceride triesters, which are generally triesters of fatty acids and of glycerol, the faty acids of which can have varied chain lengths from C4 to C24, it being possible for these chains to be saturated or unsaturated and linear or branched; these oils are in particular wheat germ oil, sunflower oil, grape seed oil, sesame oil, corn oil, apricot oil, castor oil, shea oil, avocado oil, olive oil, soybean oil, sweet almond oil, palm oil, rapeseed oil, cottonseed oil, hazelnut oil, macadamia oil, jojoba oil, alfalfa oil, poppy oil, pumpkin seed oil, marrow oil, blackcurrant oil, evening primrose oil, millet oil, barley oil, quinoa oil, rye oil, safflower oil, candlenut oil, passionflower oil, musk rose oil, and essential oils, suchAttorney Docket No. OA25160-WO-PCT / 31710-7189-PCTas Helianthus Annuus Seed Oil, Lavandula Angustifolia (lavender) Oil, Mentha Piperita Oil, Rosmarinus Officinalis (rosemary) Leaf Oil Pelargonium Graveolens flower oil, Citrus Aurantium Dulcis (orange) peel oil, Menthe Viridis (spearmint) leaf oil, Citrus Aurantifolia (lime) oil, Melaleuca Alternifolia (tea tree) leaf oil, Citrus Grandis (grapefruit) peel oil, Citrus Medica Limonum (lemon) peel oil, rose flower oil, eucalyptus globulus leaf oil, and combinations thereof;

[0257] (ii) synthetic ethers containing from 10 to 40 carbon atoms;

[0258] (iii) linear or branched hydrocarbons of mineral or synthetic origin, such as petroleum jelly, poly decenes, hydrogenated polyisobutene such as Parleam, and 40 squalane;

[0259] (iv) synthetic esters, for instance oils of formula RCOOR' in which R represents a linear or branched fatty acid residue containing from 1 to 40 carbon atoms and R' represents a hydrocarbon-based chain that is especially branched, containing from 1 to 40 carbon atoms on condition that R+R' is y 10, for instance Purcellin oil (cetearyl octanoate), isopropyl myristate, isopropyl palmitate, C12-C15 alkyl benzoate, such as the product sold under the trade name Finsolv TN(TM) or Witconol TN(TM) by Witco or Tegosoft TN(TM) by Evonik Goldschmidt, 2-ethylphenyl benzoate, such as the commercial product sold under the name X-Tend 226 by ISP, isopropyl lanolate, hexyl laurate, diisopropyl adipate, isononyl isononanoate, oleyl erucate, 2-ethylhexyl palmitate, isostearyl isostearate, diisopropyl sebacate, such as the product sold under the name of "Dub Dis" by Stearinerie Dubois, octanoates, decanoates or ricinoleates of alcohols or polyalcohols, such as propylene glycol dioctanoate; hydroxylated esters, such as isostearyl lactate or diisostearyl malate; and pentaerythritol esters; citrates or tartrates, such as di(linear C12-C13 alkyl) tartrates, such as those sold under the name Cosmacol ETI(TM) by Enichem Augusta Industriale, and also di(linear Cl 4-C15 alkyl) tartrates, such as those sold under the name Cosmacol ETL(TM) by the same company; or acetates;

[0260] (v) fatty alcohols that are liquid at room temperature, containing a branched and / or unsaturated carbon-based chain containing from 12 to 26 carbon atoms, for instance octyldodecanol, isostearyl alcohol, oleyl alcohol, 2-hexyldecanol, 2-butyloctanol or 2-undecylpentadecanol;

[0261] (vi) higher fatty acids, such as oleic acid, linoleic acid or linolenic acid;Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCT

[0262] (vii) carbonates, such as dicaprylyl carbonate, such as the product sold under the name Cetiol CC(TM) by Cognis;

[0263] (viii) fatty amides, such as isopropyl N-lauroyl sarcosinate, such as the product sold under the trade name Eldew SL 205(TM) from Ajinomoto; and

[0264] (ix) essential oils selected from the group consisting of sunflower oil, sesame oil, peppermint oil, macadamia nut oil, tea tree oil, evening primrose oil, sage oil, rosemary oil, coriander oil, thyme oil, pimento berries oil, rose oil, anise oil, balsam oil, bergamot oil, rosewood oil, cedar oil, chamomile oil, sage oil, clary sage oil, clove oil, cypress oil, eucalyptus oil, fennel oil, sea fennel oil, frankincense oil, geranium oil, ginger oil, grapefruit oil, jasmine oil, juniper oil, lavender oil, lemon oil, lemongrass oil, lime oil, mandarin oil, marjoram oil, myrrh oil, neroli oil, orange oil, patchouli oil, pepper oil, black pepper oil, petitgrain oil, pine oil, rose otto oil, rosemary oil, sandalwood oil, spearmint oil, spikenard oil, vetiver oil, wintergreen oil, and ylang ylang.

[0265] In some embodiments, the composition may include at least one branched or linear liquid alkane with carbon chain length of Cl 1 to C20. In various embodiments, liquid alkanes may be selected from those with a carbon chain length of from Cl 1 to C20. The liquid alkanes may be selected from those with a carbon chain length of from Cl 1 to C20, or from Cl 5 to Cl 9, or one of Cll, C12, C13, C14, C15, C16, C17, C18 to C19. In some particular embodiments, suitable liquid alkanes that may be used according to the disclosure include hydrocarbon-based oils containing from 8 to 16 carbon atoms, and especially branched C8-C16 alkanes such as C8-C16 isoalkanes. In some exemplary embodiments, such liquid alkanes may be chosen from isoparaffins, for instance isododecane (also known as 2,2,4,4,6-pentamethylheptane), isodecane, and isohexadecane.

[0266] The amount of each of the at least one branched or linear liquid alkane may be present in the composition in a range of from about 1% to about 35% by weight, or from about 15% to about 30% by weight, or from about 10% to about 20% or any suitable combination, subcombination, range, or sub-range thereof by weight, based on the weight of the composition. One of ordinary skill in the art, however, will appreciate that other ranges are within the scope of the invention.Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCT

[0267] Thus, each of the at least one branched or linear liquid alkane in the composition may be present by weight, based on the total weight of the composition, from about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 128, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, to about 35 percent, including increments and ranges therein and there between.

[0268] Preservatives

[0269] In some embodiments, the composition may include as additional ingredients one or more preservatives and / or antimicrobials. Thus, the composition may include or exclude one or more additional preservatives and / or antimicrobials.

[0270] Any preservative commonly used in cosmetic compositions is an acceptable preservative for the composition s herein, such as phenoxyethanol, members from the paraben family such as the methyl, ethyl, propyl, butyl or isobutyl parabens, 4-hydroxy benzoic acid, benzoic acid, sorbic acid, dehydroacetic acid, triclosan, benzyl alcohol, chlorphenesin, or salicylic acid, for example. At more concentrated amounts of suitable solvents for optional additives, in particular, suitable solvents for antimicrobials and preservatives, members from the paraben family may be used as a preservative.

[0271] In some embodiments, the one or more preservatives, when present, may be selected from phenoxyethanol, caprylyl glycol, Myrtrimonium bromide, hydroxyacetophenone, ethylhexyl glycerin, chlorphenesin, cetrimonium chloride, hexyl glycerin, octylglycerin, benzylglycerin, 3-heptoyl-2,2-propandiol, and 1,2-hexandiol; polyaminopropyl biguanide, also known as polyhexamethylene biguanide, or PHMB, and combinations thereof. In some embodiments, the composition is free or essentially free of one or more of caprylyl glycol, phenoxyethanol, hexyl glycerin, ethylhexylglycerin, octylglycerin, benzylglycerin, 3-heptoyl-2,2-propandiol, and 1,2-hexandiol; polyaminopropyl biguanide, also known as poly hexamethylene biguanide, or PHMB.

[0272] In some embodiments, the preservative may comprise one or more of preservatives selected from the group consisting of organic acids, parabens, formaldehyde donors, phenol derivatives, quaternary ammoniums, alcohols, isothiazolinones, and combinations thereof. Preservatives having antibacterial activity are optionally present in the composition s of the present invention. Examples of organic acid preservatives include, but are not limited to, sodiumAttorney Docket No. OA25160-WO-PCT / 31710-7189-PCTbenzoate, potassium sorbate, benzoic acid and dehydroacetic acid, sorbic acid, and combinations thereof. A preferred organic acid preservative system includes a mixture of sodium benzoate and potassium sorbate. Examples of paraben preservatives include, but are not limited to, alkyl parahydroxybenzoates, wherein the alkyl radical has from 1, 2, 3, 4, 5 or 6 carbon atoms and for example, from 1 to 4 carbon atoms e.g., methyl para-hydroxybenzoate (methylparaben), ethyl para-hydroxybenzoate (ethylparaben), propyl para-hydroxybenzoate (propylparaben), butyl parahydroxybenzoate (butylparaben) and isobutyl para-hydroxybenzoate (isobutylparaben). Examples of formaldehyde donor preservatives include, but are not limited to, 1,3-Dimethylol-5,5-dimethylhydantoin (DMDM hydantoin), imidazolidinyl urea, gluteraldehyde, and combinations thereof. Examples of quaternary ammonium preservatives include, but are not limited to, benzalkonium chloride, methene ammonium chloride, benzethonium chloride, and combinations thereof. Examples of alcohol preservatives include, but are not limited to, ethanol, benzyl alcohol, dichlorobenzyl alcohol, phenoxyethanol, and combinations thereof. Examples of isothiazolone preservatives include, but are not limited to, methylchloroisothiazolinone, methylisothiazolinone, and combinations thereof.

[0273] In some embodiments, the preservative includes one or more preservatives, the one or combination present at a concentration, by weight of about 0.001% to about 5%, or alternatively about 0.05% to about 2.5% or alternatively about 0.1% to about 2.0%, or from about 0.02% to about 1% by weight, or from about 0.03% to about 0.5%, or any suitable combination, subcombination, range, or sub-range thereof by weight, based upon weight of the composition. One of ordinary skill in the art, however, will appreciate that other ranges are within the scope of the invention.

[0274] Thus, any one of or a combination of preservatives, when present, may be present, by weight, based on the total weight of the composition, is from about 0.001, 0.002, 0.003,0.004, 0.005, 0.006, 0.007, 0.008, 0.009, 0.01, 0.02, 0.03,0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2, 3, 4, to about 5 weight percent, including increments and ranges therein and there between.

[0275] It will be appreciated by a skilled artisan that any optional additives are present only to the extent and in amounts that do not materially adversely affect the basic and novelAttorney Docket No. OA25160-WO-PCT / 31710-7189-PCTcharacteristic(s) of the claimed disclosure. Thus, In some embodiments, that include optional additives, such optional additives will not materially adversely affect the composition.

[0276] Further, any one or more (or all) of additional or optional additives and actives may be excluded from the composition. In other words, the composition may be free or essentially free of any or all of the additional or optional additives, actives, and other ingredients disclosed herein.

[0277] More generally, it will be appreciated by a skilled artisan that any solvents, humectants, preservatives or other additives are present only to the extent and in amounts that do not materially adversely affect the basic and novel characteristic(s) of the claimed invention.

[0278] In accordance with the various embodiments, the amount of one or more additional ingredients, such as actives and additives, alone or in combination, when present in the composition according to the disclosure can be present in a range from about 0.0001% to about 20%, and in some embodiments, from about 0.005% to about 0.01%, and in some embodiments, from about 0.01% to about 0.1%, and in some embodiments, from about 0.15% to about 5%, and in some embodiments, from about 0.40% to about 4%, and in some embodiments, from about 0.5% to about 2.5%, and in some embodiments, from about 0.1% to about 0.5% and in some embodiments, from about 1% to about 2%, or any suitable combination, sub-combination, range, or sub-range thereof by weight, based on the total weight of the composition. One of ordinary skill in the art, however, will appreciate that other ranges are within the scope of the invention.

[0279] Thus, any one or a combination of additional ingredients, such as actives and additives may be present, each one or the combination present from about 0.0001, 0.0005, 0.001, 0.002, 0.003, 0.004, 0.005, 0.006, 0.007, 0.008, 0.009, 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 0.10, 0.20, 0.30, 0.40, 0.50, 0.60, 0.70, 0.80, 0.90, 1.0, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 to about 20 percent, by weight, including increments and ranges therein and there between.

[0280] EXAMPLES

[0281] Various representative embodiments of the inventive and comparative compositions and results therewith are exemplified herein.Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCT

[0282] RAW MATERIALS

[0283] As shown below in Examples 1, 4 and 5, tested compositions include the elastomer present as a raw material (RM) comprising crosslinked polyester elastomer active and a solvent, that in the exemplified embodiments includes about 30% POLYGLYCERYL-2 ISOSTEARATE / DIMER DILINOLEATE COPOLYMER crosslinked polyester elastomer, and a solvent blend of 7.5% SQUALANE, and 62.5% COCO-CAPRYLATE / CAPRATE (designated by “ amounts of RM not final active concentration”). Thus the amounts shown in the table are not the amount of POLYGLYCERYL-2 ISOSTEARATE / DIMER DILINOLEATE COPOLYMER active.

[0284] EXAMPLE 1: Inventive Compositions:

[0285] Table 1: Inventive CompositionsINCI Name INV 1 INV 2 INV 3 INV 4 POLYGLYCERYL-2A ISOSTEARATE / DIMERvvDILINOLEATE COPOLYMER 10 5 5 5 POLYGLYCERYL-6A POLYRICINOLEATE 0.5 1 1 1 A C15-19 ALKANE 3 3 3 3 A ISOAMYL LAURATE 2 2 2 2 A TOCOPHEROL 0.1 0.1 1 B WATER (QS) ~43 ~47 ~42 ~42 B GLYCERIN 7 7 7 7 B MAGNESIUM SULFATE 2 2 2 2 B TETRASODIUM GLUTAMATE DIACETATE 0.3 0.3 0.3 0.3 B PENTYLENE GLYCOL 3 3 3 3 B HYDROXYACETOPHENONE 0.5 0.5 0.5 0.5 B ZINGIBER OFFICINALE (GINGER)ROOT EXTRACT 0.1 0.1 0.1B HYDROXYPROPYL TETRAHYDROPYRANTRIOL 4.3 4.3 4.3B GENTIANA LUTEA ROOT EXTRACT 0.5 0.5 0.5C WATER 15 15 15 15 C ASCORBIC ACID 7 7 12 15 CSODIUM HYDROXIDE 1.57 1.6 2.69 3.36Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCTD TITANIUM DIOXIDE (and) MICA 0.9Total wt% 100 100 100 100Appearance Light-beige cream-gelpH NA NA NA NA Viscosity, Brookfield*, cP 90,000 ~ 300,000 cPBulk Stability (2-month at 45 °C) PASS PASS PASS PASSFT Stability** (10-day) PASS PASS PASS PASS XXamounts of RM not final active concentration

[0286] Referencing Table 1, above, Viscosity was measured using *Brookfield Helipath T-F (#96) spindle, 10 rpm, 1 min. ** Freezing and thawing cycles at -20 °C for 12 hrs then to 25 °C for another 12 hours. Each complete cycle takes 24 hrs. A total of ten (10) cycles were applied to the test samples.

[0287] EXAMPLE 2: Comparative Compositions

[0288] Table 2: Comparative Example 1Phase INCI Name Wt %CETEARYL ALCOHOL (and) JOJOBA ESTERS (and)GLYCERYL STEARATE (and) SODIUM STEAROYLGLUTAMATE (and) HELIANTHUS ANNUUSA (SUNFLOWER) SEED WAX (and) POLYGLYCERIN-3 2A BEHENYL ALCOHOL 1A LAURETH-4 1A BUTYROSPERMUM PARKII (SHEA) BUTTER 3A POLY Cl 0-30 ALKYL ACRYLATE 0.3A CAPRYLOYL SALICYLIC ACID 0.15A DICAPRYLYL CARBONATE 3A Cl 5-19 ALKANE 2A OCTYLDODECANOL 2 AMMONIUM ACRYLO YLDIMETH YLTAUR ATE / VPAl COPOLYMER 1Al SODIUM HYALURONATE 0.1A2 TITANIUM DIOXIDE (and) MICA 0.9B WATER (QS) 44.1B GLYCERIN 7Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCTB RHAMNOSE 5 B GRIFOLA FRONDOSA FRUITING BODY EXTRACT 0.5 B PHENOXYETHANOL 0.5 B TETRASODIUM GLUTAMATE DIACETATE 0.3 B CHLORPHENESIN 0.2 B CITRIC ACID 0.05 C WATER 20 C HYDROXYPROPYL TETRAHYDROP YRANTRIOL 4.3 D ZINGIBER OFFICINALE (GINGER) ROOT EXTRACT 0.1 D GENTIANA LUTEA ROOT EXTRACT 0.5 TARAXACUM OFFICINALE (DANDELION)D RHIZOME / ROOT EXTRACT 1Total (%): 100Light Brown Appearance: Lotion pH 5.29 Viscosity, Brookfield*, cP 22,000 Bulk Stability (2-month at 45 °C) PASSFT Stability** (10-day) PASS

[0289] Table 3: Comparative Example 2Phase INCI Name Wt %CETEARYL ALCOHOL (and) JOJOBA ESTERS (and)GLYCERYL STEARATE (and) SODIUM STEAROYLGLUTAMATE (and) HELIANTHUS ANNUUSA (SUNFLOWER) SEED WAX (and) POLYGLYCERIN-3 2 A STEARYL ALCOHOL 1 A LAURETH-4 1 A BUTYROSPERMUM PARKII (SHEA) BUTTER 3 A POLY Cl 0-30 ALKYL ACRYLATE 0.3 A CAPRYLOYL SALICYLIC ACID 0.15 A DICAPRYL YL CARBONATE 3 A Cl 5-19 ALKANE 2 A OCTYLDODECANOL 2 Cl 2-22 ALKYLACRYLATE / HYDROXYETHYLACRYLATEA COPOLYMER 1Atorney Docket No. OA25160-WO-PCT / 31710-7189-PCTAl SCLEROTIUM GUM (and) XANTHAN GUM (75 / 25) 1 Al SODIUM HYALURONATE 0.1 A2 TITANIUM DIOXIDE (and) MICA 0.9 B WATER (QS) 26.08 B GLYCERIN 7 B PHENOXYETHANOL 0.5 B TETRASODIUM GLUTAMATE DIACETATE 0.3 B CHLORPHENESIN 0.2 B HYDROXYPROPYL TETR AH YDROPYRANTRIOL 4.3 B ZINGIBER OFFICINALE (GINGER) ROOT EXTRACT 0.1 B GENTIANA LUTEA ROOT EXTRACT 0.5 WATER 20 C WATER 15 C ASCORBIC ACID 7 C SODIUM HYDROXIDE 1.57Total (%): 100 Light Brown Appearance: Lotion pH 5.85 Viscosity, Brookfield*, cP 29,000 Bulk Stability (2-month at 45 °C) PASSFT Stability** (10-day) PASS

[0290] Table 4: Comparative Example 3Phase INCI Name Wt % A SORBITAN TRISTEARATE 2 POLYGLYCERYL-3 METHYLGLUCOSEA DISTEARATE 1 A ISOPROPYL LAUROYL S ARCOSINATE 8 A DIISOPROPYL SEBACATE 3 A STEARYL ALCOHOL 0.4 A OCTYLDODECANOL 2 A CAPRYLOYL SALICYLIC ACID 0.15 Cl 2-22 ALKYLACRYLATE / HYDROXYETHYLACRYLATEA COPOLYMER 1 A HYDROXYACETOPHENONE 0.5A TOCOPHEROL 0.1Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCTAl SCLEROTIUM GUM 0.8A2 TITANIUM DIOXIDE (and) MICA 0.9B WATER (QS) 38.43B GLYCERIN 7B PROPANEDIOL 2B PENTYLENE GLYCOL 3B SODIUM STEAROYL GLUTAMATE 0.75B TETRASODIUM GLUTAMATE DIACETATE 0.5 HYDROXYPROPYL B TETRAHYDROPYRANTRIOL 4.3B GENTIANA LUTEA ROOT EXTRACT 0.5 ZINGIBER OFFICINALE (GINGER) ROOTB EXTRACT 0.1C WATER 15C ASCORBIC ACID 7C SODIUM HYDROXIDE 1.57Total (%): 100Light Beige Cream- Appearance: Gel pH 5.88 Viscosity, Brookfield*, cP 23,000 Bulk Stability (2-month at 45 °C) PASSFT Stability** (10-day) PASS

[0291] EXAMPLE 3: Noodle (Pilling) Test

[0292] Noodle (Pilling) Test on Chinese female consumers. The results were taken from the average of 6 female with evenly distributed skin types (oily, combination and dry). A fixed amount of test product was applied on the face of test subjects. Upon drying of the test product, a trained esthetician would apply certain gesture onto the skin. The presence of noodle (pilling) on face was assessed and given a score of 0 to 6 (0 being “no noodle,” while 6 being “severe noodling”). A score of 0 to 1.49 is acceptable by consumers, while a score of greater that 1.50 is not acceptable and considered as annoying to the consumers.

[0293] Table 5: Noodle (Pilling) Test ResultsTest Formulas Noodle Score (0 to 6) ResultsAttorney Docket No. OA25160-WO-PCT / 31710-7189-PCTInv 2 1.00Comparative Example 1 2.83Comparative Example 2 3.33Comparative Example 3 2.50

[0294] The Noodle levels of all three comparative examples are considered “High”; while “Inventive Example 2” gives “low / medium” noodle potential and is considered as acceptable by consumers.

[0295] EXAMPLE 4: Effect of different Co-Emulsifiers

[0296] Table 5: Effect of different Co-EmulsifiersINCI Name Inv 5 Inv 6 Comp Comp Comp Comp 4 5 6 7 A POLYGLYCERYL-2 10 5 10 5 5 5 ISOSTEARATE / DIMERDILINOLEATE COPOLYMERXXA POLYGLYCERYL-6 0.5 0.5POLYRICINOLEATE A POLYGLYCERYL-4 0.5 ISOSTEARATE[Isolan GI34 from Evonik]A POLYGLYCERYL-4 0.5 0.5DIISO STEARATE / POLYHYDROXYSTEARATE / SEBACATE (and)CAPRYLIC / CAPRICTRIGLYCERIDE (and)POLYGLYCERYL-3OLEATE (and)DIISOSTEAROYL POLYGLYCERYL-3 DIMERDILINOLEATE[Isolan 17MB from Evonik]Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCTA POLYGLYCERYL-4 0.5 DIISO STEARATE / POLYHYDROXYSTEARATE / SEBACATE[Isolan GPS from Evonik]A Cl 5-19 ALKANE 3 3 3 3 3 3 A ISOAMYL LAURATE 2 2 2 2 2 2 B WATER (QS) 71.885 76.885 71.885 76.885 76.885 76.885 B GLYCERIN 7 7 7 7 7 7 B MAGNESIUM SULFATE 2 2 2 2 2 2 B TETRASODIUM 0.1 0.1 0.1 0.1 0.1 0.1 GLUTAMATE DIACETATE B PENTYLENE GLYCOL 3 3 3 3 3 3 B HYDROXYACETOPHENO 0.5 0.5 0.5 0.5 0.5 0.5 NE B CITRIC ACID 0.015 0.015 0.015 0.015 0.015 0.015 Total wt% 100 100 100 100 100 100 pH (no measurable pH) NA NA NA NA NA NA Viscosity, Brookfield*, cP 110,000 81,000 28,000 NA 22,000 22,001 Bulk Stability (2 months at 45 PASS PASS Fail Fail Fail Fail °C)FT Stability** (10 cycles) PASS PASS S epara S epara S epara S eparated ted ted ted XXamounts of RM not final active concentration

[0297] As shown in Table 5, the inventive compositions containing POLYGLYCERYL-6 POLYRICINOLEATE perform well in terms of stability and viscosity, while unexpectedly, the generally similar emulsifiers Polyglyceryl-4 Isostearate, Polyglyceryl-4 Diisostearate / Polyhydroxystearate / Sebacate (And) Caprylic / Capric Triglyceride (And) Polyglyceryl-3 Oleate (And) Diisostearoyl Polyglyceryl-3 Dimer Dilinoleate, Polyglyceryl-4 Diisostearate / Polyhydroxystearate / Sebacate fall short of providing suitable viscosity, and demonstrate unstable emulsions.

[0298] EXAMPLE 5: Viscosity: Varied ratios of Polyglyceryl-2 Isostearate / Dimer Dilinoleate Copolymer (Emulsifier A) and Polyglyceryl-6 Polyricinoleate (Emulsifier B)

[0299] Several formulas were made following the compositions shown below in Table 6 for evaluation of the effect of varied ratios of Polyglyceryl-2 Isostearate / Dimer Dilinoleate Copolymer (Emulsifier A) elastomer gel and Polyglyceryl-6 Polyricinoleate (Emulsifier B).Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCT

[0300] Table 6: Effect of Primary and secondary EmulsifierPhase INCI Wt %POLYGLYCERYL-2A ISOSTEARATE / DIMER DILINOLEATECOPOLYMER (Emulsifier AXXX POLYGLYCERYL-6 POLYRICINOLEATEA(Emulsifier B) YA Cl 5-19 ALKANE 3A ISO AMYL LAURATE 2B WATER (QS) QS to 100B GLYCERIN 7B MAGNESIUM SULFATE 2B TETRASODIUM GLUTAMATE DIACETATE 0.1B PENTYLENE GLYCOL 3B HYDROXYACETOPHENONE 0.5B CITRIC ACID 0.015Total wt% 100XXamounts of RM not final active concentration

[0301] Viscosity was analyzed using a Brookfield Helipath T-F (#96) spindle with a spinning speed of 10 rpm for 1 minute. Results are shown in Table 7, below. As shown, *Composition F could not be formed.

[0302] Table 7: Effect of Primary and secondary Emulsifier (Viscosity and Phase Stability)Compositions Emulsifier A Emulsifier B Viscosity, cP StabilityA 10 0.5 110,000 PASSB 10 0.2 30,000 PASSC 10 0 12,000 FAILD 5 0.5 81,000 PASSE 5 0.2 22,000 PASSF 5 0 NA* NA*Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCTG 3 0.5 74,000 PASSH 3 0.2 37,000 BorderlineI 3 0.1 32,000 FAILJ 1 1 145,000 PASSK 0 1 107,000 FAILL 0 0.5 53,000 FAIL* Composition F could not form an emulsion

[0303] As shown in Table 7, the stability of inventive compositions with varied proportions of the emulsifiers Polyglyceryl-2 Isostearate / Dimer Dilinoleate Copolymer (in an elastomer gel comprising solvent) and Polyglyceryl-6 Polyricinoleate is dependent on the ratio of the Polyglyceryl-2 Isostearate / Dimer Dilinoleate Copolymer elastomer gel to Polyglyceryl-6 Polyricinoleate. As demonstrated, suitable viscosity and stability are accomplished in those inventive embodiments in which the Polyglyceryl-2 Isostearate / Dimer Dilinoleate Copolymer elastomer gel and Polyglyceryl-6 Polyricinoleate are present in a ratio of the Polyglyceryl-2 Isostearate / Dimer Dilinoleate Copolymer elastomer gel to Polyglyceryl-6 Polyricinoleate that is at least 1.0 by weight, based on the weight of each ingredient.

[0304] While the disclosure has been described with reference to an embodiment, it will be understood by those skilled in the art that various changes may be made and equivalents may be substituted for elements thereof without departing from the scope of the disclosure. In addition, many modifications may be made to adapt a particular situation or material to the teachings of the disclosure without departing from the essential scope thereof. Therefore, it is intended that the disclosure not be limited to the particular embodiment disclosed as the best mode contemplated for carrying out this disclosure, but that the disclosure will include all embodiments falling within the scope of the appended claims.

[0305] The articles “a” and “an,” as used herein, mean one or more when applied to any feature in embodiments of the present disclosure described in the specification and claims. The use of “a” and “an” does not limit the meaning to a single feature unless such a limit is specifically stated. The article “the” preceding singular or plural nouns or noun phrases denotes a particular specified feature or particular specified features and may have a singular or plural connotationAttorney Docket No. OA25160-WO-PCT / 31710-7189-PCTdepending upon the context in which it is used. The adjective “any” means one, some, or all indiscriminately of whatever quantity.

[0306] ‘ ‘At least one,” as used herein, means one or more and thus includes individual components as well as mixtures / combinations.

[0307] The transitional terms “comprising,” “consisting essentially of’ and “consisting of,” when used in the appended claims, in original and amended form, define the claim scope with respect to what unrecited additional claim elements or steps, if any, are excluded from the scope of the claim(s). The term “comprising” is intended to be inclusive or open-ended and does not exclude any additional, unrecited element, method, step or material. The term “consisting of’ excludes any element, step or material other than those specified in the claim and, in the latter instance, impurities ordinarily associated with the specified material(s). The term “consisting essentially of’ limits the scope of a claim to the specified elements, steps or material(s) and those that do not materially affect the basic and novel characteristic(s) of the claimed disclosure. All materials and methods described herein that embody the present disclosure can, in alternate embodiments, be more specifically defined by any of the transitional terms “comprising,” “consisting essentially of,” and “consisting of.”

[0308] ‘ ‘Free” and “devoid” and “exclude” or “excluded” each indicates that no reliably measurable excluded material, for example, an excluded thickener or excluded sulfate surfactant or other excluded material as described herein, is present in the composition. The term “essentially free” means that, while it is preferred that no excluded material is present in the composition, it is possible to have very small amounts of the excluded material in the composition of the invention, provided that these amounts do not materially affect the advantageous properties of the composition. In particular, “essentially free” means that excluded material can be present in the composition at an amount of less than 5%, or less than 4%, or less than 3%, or less than 2%, or less than 1%, or less than 0.1% by weight, or at 0%, based on the total weight of the composition. In accordance with the various embodiments, it is contemplated that some or all of following ingredients may be included in or excluded from the composition according to the invention: alcohols, for example but not limited to, monohydric alcohols; powders comprising Nylon- 12, polymethyl methacrylate, polyethylene beads, and powders which are consideredAttorney Docket No. OA25160-WO-PCT / 31710-7189-PCTmicroplastics; polyethylene glycol (PEG) and polypropylene glycol (PPG) containing compounds, including PEG and PPG thickeners and surfactants, PEG / PEO polymeric thickeners; sulfate containing compounds, including sulfate surfactants; silicones, including silicone polymers, silicone elastomers, and silicone oils; petrochemicals, including mineral oil; phthalates, parabens; polyquaternium compounds; microplastics; synthetic dyes; gelling agents; and combinations thereof.

[0309] The composition may include or exclude one or more polymers and polymeric thickeners. In some embodiments, the composition may include or exclude one or more polymers such as cationic polymers selected from polylysine, chitosan, and guar. In some embodiments, the composition may exclude one or more polymers selected from disaccharides, polysaccharides that include alginates / algin, chitosan, cyclodextrin, cationic gelatin, cationic dextran, celluloses, cationic cellulose, chitin, starches, galactomannans such as guar gums and its derivatives, including hydroxypropyl guar, cationic guar derivatives, gums of microbial origin, including xanthan gum, scleroglucan gum, mucopolysaccharides, chondroitin sulfates, and mixtures thereof, and gums derived from plant exudates, including locust bean gums, gum arabic, ghatti gum, karaya gum, gum tragacanth, carrageenan gum, agar gum and carob gum, cellulose-based polymers, including methylcellulose, hydroxyalkylcellulose, ethylhydroxyethylcelluloses, hydroxyethylcellulose, hydroxypropylcellulose, carboxymethylcellulose, cationic cellulose ether derivatives, quaternized cellulose derivatives, nitrocellulose, hemicellulose and hemicellulose derivatives, mannans, xylans, lignins, arabans, galacturonans, alginate-based compounds, glucuronoxylans, arabinoxylans, xyloglucans, glucomannans, fructosans such as inulin, pectic acids and pectins, arabinogalactans, agars, glycosaminoglycans, gelatin, gellan, crosslinked homopolymers of acrylic acid, cationic peptides and their derivatives (e.g., polylysine, polyornithine), peptide / protein polymers (e.g., histone, collagen); cationic thiolated biopolymers (nature-based thiomers or nature-based dendrimers, e.g., chitosan-cysteine, chitosanthiobutylamidine, chitosan-thioglycolic acid); algin, xanthan gum (and) sclerotium gum (and) lecithin (and) pullulan (Siligel (TM)), xanthan gum, carbomer 980, hydroxypropyl starch phosphate, ammonium polyacryloyldimethyl taurate, hydroxy ethyl cellulose, acrylate copolymer, sclerotium gum; or combinations thereof.Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCT

[0310] Other than in the operating examples, or where otherwise indicated, all numbers expressing quantities of ingredients and / or reaction conditions may be understood as being modified in all instances by the term “about,” meaning within 10% of the indicated number (e.g., “about 10%” means 9% - 11% and “about 2%” means 1.8% - 2.2%).

[0311] All percentages and ratios are calculated by weight unless otherwise indicated. All percentages are calculated based on the total composition unless otherwise indicated. Generally, unless otherwise expressly stated herein, “weight” or “amount” as used herein with respect to the percent amount of an ingredient refers to the amount of the raw material comprising the ingredient, wherein the raw material may be described herein to comprise less than and up to 100% activity of the ingredient. Therefore, weight percent of an active in a composition is represented as the amount of raw material containing the active that is used, and may or may not reflect the final percentage of the active, wherein the final percentage of the active is dependent on the weight percent of active in the raw material.

[0312] All ranges and amounts given herein are intended to include subranges and amounts using any disclosed point as an end point. Thus, a range of “1% to 10%, such as 2% to 8%, such as 3% to 5%,” is intended to encompass ranges of “1% to 8%,” “1% to 5%,” “2% to 10%, ” and so on. All numbers, amounts, ranges, etc., are intended to be modified by the term “about,” whether or not so expressly stated. Similarly, a range given of “about 1% to 10%” is intended to have the term “about” modifying both the 1% and the 10% endpoints. Further, it is understood that when an amount of a component is given, it is intended to signify the amount of the active material unless otherwise specifically stated.

[0313] Notwithstanding that the numerical ranges and parameters setting forth the broad scope of the disclosure are approximations, unless otherwise indicated the numerical values set forth in the specific examples are reported as precisely as possible. Any numerical value, however, inherently contains certain errors necessarily resulting from the standard deviation found in their respective testing measurements. The example that follows serves to illustrate embodiments of the present disclosure without, however, being limiting in nature.

[0314] All publications and patent applications cited in this specification are herein incorporated by reference, and for any and all purposes, as if each individual publication or patentAttorney Docket No. OA25160-WO-PCT / 31710-7189-PCTapplication were specifically and individually indicated to be incorporated by reference. In the event of an inconsistency between the present disclosure and any publications or patent application incorporated herein by reference, the present disclosure controls.

Claims

Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCTWHAT IS CLAIMED IS:1) A cosmetic composition comprising:a) an emulsion system comprising at least two emulsifiers, wherein the emulsifiers comprise:i) from about 1% to about 10% of an elastomer gel that comprises a crosslinked polyester elastomer and a solvent, by weight, based on the weight of the composition; ii) from about 0.2% to about 1% of Polyglyceryl-6 Polyricinoleate by weight, based on the weight of the composition;b) ascorbic acid or a derivative thereof;wherein, the elastomer comprises a reaction product of:(i) at least one di-carboxylic acid or tri-carboxylic acid; (ii) at least one monocarboxylic acid; and (iii) at least one polyol, wherein the at least one di-carboxylic acid is a compound of formula (IA)o oL Aia)HO R1AOHwherein R1Ais C2-C52 alkyl group, C2-C52 heteroalkyl group, C2-C52 alkene group, C2-C52 heteroalkene group, C3-C52 cyclic group, or C2-C52 heterocyclic group, and wherein the at least one tri-carboxylic acid is a compound of formula (IB)(IB)wherein R1Bis C2-C52 alkyl group, C2-C52 heteroalkyl group, C2-C52 alkene group, C2-C52 heteroalkene group, C3-C52 cyclic group, or C2-C52 heterocyclic group,and wherein the at least one mono- carboxylic acid is a compound of formula (II)Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCToII (H)R2OHwherein R2is C2-C52 alkyl group, C2-C52 heteroalkyl group, C2-C52 alkene group, C2-C52 heteroalkene group, C3-C52 cyclic group, or C2-C52 heterocyclic group, and wherein the at least one polyol is a compound of formula (III) R3-|-OH]N(in)wherein R3is C3-C50 alkyl group, C3-C50 heteroalkyl group, C3-C50 alkene group, C3- C50 heteroalkene group, C3-C50 cyclic group, or C3-C50 heterocyclic group; and n is an integer from 2 to 10, andwherein the composition is a water-in-oil emulsion comprising an oil phase and an internal water phase with a concentration of the internal water phase that is at least 74% by weight, based on the weight of the composition, andwherein the elastomer gel and Polyglyceryl-6 Polyricinoleate are present in a ratio of the elastomer gel elastomer gel to Polyglyceryl-6 Polyricinoleate that is at least 1 : 1 by weight, based on the weight of each ingredient, andwherein the combination of the elastomer gel and Polyglyceryl-6 Polyricinoleate is at least 2% by weight, based on the weight of the composition, andwherein the composition, when subjected to shear, releases the water phase from the oil phase and melts from a thick cream to a watery liquid.2) The cosmetic composition according to claim 1 , wherein the cosmetic composition is characterized by one or more features selected from the group consisting of: the crosslinked polyester elastomer comprises Polyglyceryl-2 Isostearate / Dimer Dilinoleate Copolymer; the elastomer gel is present in a range from about 5% to about 10% by weight, based on the weight of the composition; the Polyglyceryl-6 Polyricinoleate is present in a range from about 0.5% to about 1% by weight, based on the weight of the composition; and combinations thereof.Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCT3) The cosmetic composition according to claim 1, wherein the composition includes at least one additional emulsifier that is different from crosslinked polyester elastomer and Polyglyceryl-6 Polyricinoleate.4) The cosmetic composition according to claim 1 , wherein the composition excludes an emulsifier selected from the group consisting of Polyglyceryl-4 Isostearate, Polyglyceryl-3 Diisostearate, Polyglyceryl-3 Polyricinoleate, Polyglyceryl-4 Diisostearate / Polyhydroxystearate / Sebacate (And) Caprylic / Capric Triglyceride (And) Polyglyceryl-3 Oleate (And) Diisostearoyl Polyglyceryl-3 Dimer Dilinoleate, Polyglyceryl-4 Diisostearate / Polyhydroxystearate / Sebacate, and combinations thereof.5) The cosmetic composition according to claim 1 , wherein the cosmetic composition is characterized by one or more features selected from the group consisting of: the ascorbic acid is present in the composition in a range from about 5% to about 20% by weight, based on the weight of the composition; the internal water phase is present in a range from about 74% to about 90% by weight, based on the weight of the composition; the oil phase does not exceed 20% by weight, based on the weight of the composition; water is present in a range from about 40% to about 80% by weight, based on the weight of the composition; and combinations thereof.6) The cosmetic composition according to claim 1 , wherein the composition demonstrates one or more of the following: (i) a viscosity in a range from about 30,000 cP to about 300,000 cP; (ii) emulsion and viscosity stability when exposed to at least ten 24-hour freeze / thaw cycles at freezing temperatures of about -20 °C and thaw temperatures of about 25 °C; (iii) stability of the ascorbic acid or derivative thereof as demonstrated by lack of precipitation and crystallization, and lack of visibly detectable color change after at least two months at ambient and elevated temperatures of about 25 °C and 45 °C, respectively; (iv) resistance to pilling or noodling on application of shear when applied to a keratinous substate at a temperature of about 25 °C; (v) the cosmetic composition is free of silicone elastomer, and (vi) combinations thereof.7) The cosmetic composition according to claim 1 , wherein the composition includes an ingredient selected from the group consisting of Cl 5-19 Alkane, Isoamyl Laurate, Tocopherol, Glycerin, Magnesium Sulfate, Tetrasodium Glutamate Diacetate, PentyleneAttorney Docket No. OA25160-WO-PCT / 31710-7189-PCTGlycol, Hydroxyacetophenone, Zingiber Officinale (Ginger) Root Extract, Hydroxypropyl Tetrahydropyrantriol, Gentiana Lutea Root Extract, Sodium Hydroxide, Titanium Dioxide (And) Mica, and combinations thereof.8) The cosmetic composition according to claim 1 , wherein the internal water phase is present at about 89% by weight, based on the weight of the composition.9) The cosmetic composition according to claim 1, wherein ascorbic acid is present in the composition in a range from about 7% to about 15% by weight, based on the weight of the composition.10) A cosmetic composition comprising:a) an emulsion system comprising at least two emulsifiers comprising:i) an elastomer gel that comprises Polyglyceryl-2 Isostearate / Dimer Dilinoleate Copolymer and a solvent; andii) Polyglyceryl-6 Polyricinoleate;b) ascorbic acid or a derivative thereof;wherein the composition is a water-in-oil emulsion comprising an oil phase and an internal water phase with a concentration of the internal water phase that is at least 74% by weight, based on the weight of the composition.11) The cosmetic composition according to claim 10, wherein the composition is free of silicone elastomer.12) The cosmetic composition according to claim 10, wherein the Polyglyceryl-2 Isostearate / Dimer Dilinoleate Copolymer elastomer gel and Polyglyceryl-6 Polyricinoleate are present in a ratio of the Polyglyceryl-2 Isostearate / Dimer Dilinoleate Copolymer elastomer gel to Polyglyceryl-6 Polyricinoleate that is at least 1 : 1 by weight, based on the weight of each ingredient.13) The cosmetic composition according to claim 10, wherein the Polyglyceryl-2 Isostearate / Dimer Dilinoleate Copolymer elastomer gel and Polyglyceryl-6 Polyricinoleate are present in a ratio of the Polyglyceryl-2 Isostearate / Dimer Dilinoleate CopolymerAttorney Docket No. OA25160-WO-PCT / 31710-7189-PCTelastomer gel to Polygly eery 1-6 Polyricinoleate that is in a range from about 1 : 1 to about 20: 1 by weight, based on the weight of each ingredient.14) The cosmetic composition according to claim 10, wherein the combination of the Polyglyceryl-2 Isostearate / Dimer Dilinoleate Copolymer elastomer gel and Polygly ceryl-6 Polyricinoleate is at least 2% by weight, based on the weight of the composition, wherein the Polyglyceryl-2 Isostearate / Dimer Dilinoleate Copolymer elastomer gel is present from about 1% to about 10% by weight, based on the weight of the composition, and wherein Polygly eery 1-6 Polyricinoleate is present from about 0.5% to about 1% by weight, based on the weight of the composition, andwherein the composition demonstrates one or more of the following: (i) a viscosity in a range from about 30,000 cP to about 300,000 cP; (ii) emulsion and viscosity stability when exposed to at least ten 24-hour freeze / thaw cycles at freezing temperatures of about -20 °C and thaw temperatures of about 25 °C; (iii) stability of the ascorbic acid or derivative thereof as demonstrated by lack of precipitation and crystallization, and lack of visibly detectable color change after at least two months at ambient and elevated temperatures of about 25 °C and 45 °C, respectively; (iv) resistance to pilling or noodling on application of shear when applied to a keratinous substate at a temperature of about 25 °C; (v) when subjected to shear, the composition releases the water phase from the oil phase and melts from a thick cream to a watery liquid; and (vi) combinations thereof.15) A cosmetic composition comprising:a) an emulsion system comprising at least two emulsifiers comprising:i) from about 1% to about 10% of an elastomer gel that comprises Polyglyceryl-2 Isostearate / Dimer Dilinoleate Copolymer and a solvent, by weight, based on the weight of the composition;ii) from about 0.5% to about 1% of Polygly ceryl-6 Polyricinoleate by weight, based on the weight of the composition;b) ascorbic acid or a derivative thereof present in a range from about 5% to about 20% by weight, based on the weight of the composition;Attorney Docket No. OA25160-WO-PCT / 31710-7189-PCTwherein the composition is a water-in-oil emulsion comprising an oil phase and an internal water phase with a concentration of the internal water phase that is at least 74% by weight, based on the weight of the composition, andwherein the oil phase does not exceed 20% by weight, based on the weight of the composition, andwherein the composition demonstrates emulsion and viscosity stability when exposed to at least ten 24-hour freeze / thaw cycles at freezing temperatures of about -20 °C and thaw temperatures of about 25 °C, andwherein the internal water phase is present at about 89% by weight, based on the weight of the composition, and wherein ascorbic acid is present in the composition in a range from about 7% to about 15% by weight, based on the weight of the composition.